<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">96678</article-id><article-id pub-id-type="doi">10.7554/eLife.96678</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.96678.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Released bacterial ATP shapes local and systemic inflammation during abdominal sepsis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Spari</surname><given-names>Daniel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5028-0851</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Schmid</surname><given-names>Annina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Sanchez-Taltavull</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Murugan</surname><given-names>Shaira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Keller</surname><given-names>Keely</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ennaciri</surname><given-names>Nadia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Salm</surname><given-names>Lilian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6812-3678</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Stroka</surname><given-names>Deborah</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3517-3871</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Beldi</surname><given-names>Guido</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9914-3807</contrib-id><email>guido.beldi@insel.ch</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q9sj412</institution-id><institution>Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University Hospital of Bern</institution></institution-wrap><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q9sj412</institution-id><institution>Department for BioMedical Research, Visceral Surgery and Medicine, University Hospital of Bern</institution></institution-wrap><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Takeda</surname><given-names>Kiyoshi</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Osaka University</institution></institution-wrap><country>Japan</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Garrett</surname><given-names>Wendy S</given-names></name><role>Senior Editor</role><aff><institution>Harvard T.H. Chan School of Public Health</institution><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>20</day><month>08</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP96678</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-03-06"><day>06</day><month>03</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-03-08"><day>08</day><month>03</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.03.07.583973"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-04-19"><day>19</day><month>04</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96678.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-07-15"><day>15</day><month>07</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96678.2"/></event></pub-history><permissions><copyright-statement>© 2024, Spari et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Spari et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-96678-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-96678-figures-v1.pdf"/><abstract><p>Sepsis causes millions of deaths per year worldwide and is a current global health priority declared by the WHO. Sepsis-related deaths are a result of dysregulated inflammatory immune responses indicating the need to develop strategies to target inflammation. An important mediator of inflammation is extracellular adenosine triphosphate (ATP) that is released by inflamed host cells and tissues, and also by bacteria in a strain-specific and growth-dependent manner. Here, we investigated the mechanisms by which bacteria release ATP. Using genetic mutant strains of <italic>Escherichia coli</italic> (<italic>E. coli</italic>), we demonstrate that ATP release is dependent on ATP synthase within the inner bacterial membrane. In addition, impaired integrity of the outer bacterial membrane notably contributes to ATP release and is associated with bacterial death. In a mouse model of abdominal sepsis, local effects of bacterial ATP were analyzed using a transformed <italic>E. coli</italic> bearing an arabinose-inducible periplasmic apyrase hydrolyzing ATP to be released. Abrogating bacterial ATP release shows that bacterial ATP suppresses local immune responses, resulting in reduced neutrophil counts and impaired survival. In addition, bacterial ATP has systemic effects via its transport in outer membrane vesicles (OMV). ATP-loaded OMV are quickly distributed throughout the body and upregulated expression of genes activating degranulation in neutrophils, potentially contributing to the exacerbation of sepsis severity. This study reveals mechanisms of bacterial ATP release and its local and systemic roles in sepsis pathogenesis.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Sepsis is a severe condition often caused by the body’s immune system overreacting to bacterial infections. This can lead to excessive inflammation which damages organs and requires urgent medical care. With sepsis claiming millions of lives each year, new and improved ways to treat this condition are urgently needed. One potential strategy for treating sepsis is to target the underlying mechanisms controlling inflammation.</p><p>Inflamed and dying cells release molecules called ATP (the energy carrier of all living cells), which strongly influence the immune system, including during sepsis. In the early stages of an infection, ATP acts as a danger signal warning the body that something is wrong. However, over time, it can worsen infections by disturbing the immune response.</p><p>Similar to human cells, bacteria release their own ATP, which can have different impacts depending on the type of bacteria and where they are located in the body. However, it is not well understood how bacterial ATP influences severe infections like sepsis.</p><p>To investigate this question, Spari et al analysed how ATP is released from <italic>Escherichia coli</italic>, a type of bacteria that causes severe infections<italic>.</italic> This revealed that the bacteria secrete ATP directly in to their environment and via small membrane-bound structures called vesicles.</p><p>Spari et al. then probed a mouse model of abdominal sepsis which had been infected with <italic>E. coli</italic> that release either normal or low levels of ATP. They found that the ATP released from <italic>E. coli</italic> impaired the mice’s survival and lowered the number of neutrophils (immune cells which are important for defending against bacteria) at the site of the infection. The ATP secreted via vesicles also altered the role of neutrophils but in more distant regions, and it is possible that these changes may be contributing to the severity of sepsis.</p><p>These findings provide a better understanding of how ATP released from bacteria impacts the immune system during sepsis. While further investigation is needed, these findings may offer new therapeutic targets for treating sepsis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>bacterial ATP</kwd><kwd>ATP</kwd><kwd>OMV</kwd><kwd>inflammation</kwd><kwd>sepsis</kwd><kwd><italic>E. coli</italic></kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Swiss National Science Foundation</institution></institution-wrap></funding-source><award-id>166594</award-id><principal-award-recipient><name><surname>Beldi</surname><given-names>Guido</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Bacteria release ATP as part of their attack in sepsis.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Worldwide, 11 million sepsis-related deaths were reported in 2017, which accounted for an estimated 19.7% of all global deaths (<xref ref-type="bibr" rid="bib69">Rudd et al., 2020</xref>). Given its high incidence and immense socio-economic burden, the World Health Organization (WHO) has declared sepsis as a global health priority (<xref ref-type="bibr" rid="bib65">Reinhart et al., 2017</xref>).</p><p>Sepsis is defined as life-threatening organ dysfunction caused by an imbalanced host immune response to infection. Antibiotic treatment remains the main approach to treat sepsis; however, despite the use of broad-spectrum antibiotics, lethality remains high. Immune-modulating strategies are an additional approach to antibiotics to curb excessive inflammation and to support an effective defense against the infectious agents. Until recently however, most trials inhibiting cytokine responses or Toll-like receptors failed, indicating that alternative approaches for immunomodulation are required (<xref ref-type="bibr" rid="bib13">Cao et al., 2023</xref>).</p><p>It has been shown that adenosine triphosphate (ATP), as soon as it is released into the extracellular space, critically modulates inflammatory and immune responses (<xref ref-type="bibr" rid="bib19">Di Virgilio et al., 2020</xref>; <xref ref-type="bibr" rid="bib23">Eltzschig et al., 2012</xref>) by activating ionotropic P2X and metabotropic P2Y receptors (<xref ref-type="bibr" rid="bib12">Burnstock, 2020</xref>; <xref ref-type="bibr" rid="bib34">Junger, 2011</xref>). Also, such purinergic signaling critically alters immune responses during sepsis (<xref ref-type="bibr" rid="bib21">Dosch et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">Ledderose et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Spari and Beldi, 2020</xref>). In particular, we have described that the connexin-dependent release of ATP by macrophages initiates an autocrine loop of over-activation, resulting in altered local and systemic cytokine secretion, which exacerbates abdominal sepsis (<xref ref-type="bibr" rid="bib21">Dosch et al., 2019</xref>). Such sepsis-promoting effects of host-derived extracellular ATP are secondary to inflammation initiated by bacterial pathogens.</p><p>Recently, it has been discovered that also bacteria release ATP into the extracellular space (<xref ref-type="bibr" rid="bib51">Mempin et al., 2013</xref>). Such ATP release might be a conserved mechanism of protection from host defense and precede host responses. ATP release has been shown for a variety of bacteria including the sepsis-associated <italic>Escherichia coli</italic> (<italic>E. coli</italic>) and <italic>Klebsiella pneumoniae</italic> (<italic>K. pneumoniae</italic>) from the Proteobacteria phylum or <italic>Enterococcus faecalis</italic> (<italic>E. faecalis</italic>) and <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>) from the Firmicutes phylum (<xref ref-type="bibr" rid="bib16">Diekema et al., 2019</xref>; <xref ref-type="bibr" rid="bib29">Hironaka et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Iwase et al., 2010</xref>; <xref ref-type="bibr" rid="bib51">Mempin et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Mureșan et al., 2018</xref>).</p><p>The mechanisms by which inflammatory and immune responses in the host are modulated by such released bacterial ATP have just begun to be elucidated (<xref ref-type="bibr" rid="bib75">Spari and Beldi, 2020</xref>). In colonized compartments such as the intestine, it has been shown that ATP released by mutualistic bacteria modulates local cellular and secretory immune responses (<xref ref-type="bibr" rid="bib4">Atarashi et al., 2008</xref>; <xref ref-type="bibr" rid="bib60">Perruzza et al., 2017</xref>; <xref ref-type="bibr" rid="bib61">Proietti et al., 2019</xref>) and in the mouth, bacterial ATP release leads to biofilm dispersal and periodontitis (<xref ref-type="bibr" rid="bib17">Ding et al., 2016a</xref>; <xref ref-type="bibr" rid="bib18">Ding and Tan, 2016b</xref>). However, the role of ATP released by bacteria invading non-colonized compartments, such as the abdominal cavity or the blood in the context of local and systemic infections, remains to be determined.</p><p>In this study, we investigated if ATP released from bacteria influences the outcome of abdominal sepsis. We first isolated sepsis-associated bacteria and measured the amount of ATP they release. Second, we analyzed the function of the inner bacterial membrane on ATP release over time in <italic>E. coli</italic> and in <italic>E. coli</italic> with mutations in integral respiratory chain proteins (<xref ref-type="bibr" rid="bib51">Mempin et al., 2013</xref>). Third, the function of the outer bacterial membrane on ATP release during growth was assessed using porin mutants (<xref ref-type="bibr" rid="bib1">Alvarez et al., 2017</xref>; <xref ref-type="bibr" rid="bib15">Choi and Lee, 2019</xref>). Fourth, we investigated local effects of ATP in the abdominal cavity. Lastly, based on the finding that bacteria secrete outer membrane vesicles (OMV) (<xref ref-type="bibr" rid="bib72">Schwechheimer and Kuehn, 2015</xref>), we investigated systemic consequences of released bacterial ATP.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>E. coli</italic>, one of the major pathogens in sepsis, releases ATP in a growth-dependent manner</title><p>To assess ATP release of sepsis-associated bacteria, abdominal fluid of patients with abdominal sepsis was sampled and an/aerobically incubated on LB agar plates (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Twenty-five different colonies were randomly picked and analyzed by whole 16S-rRNA Sanger sequencing, which resulted in 12 different bacterial species (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). From these, the four most clinically important sepsis-associated bacteria <italic>E. coli, K. pneumoniae</italic> (both gram<sup>neg</sup>), <italic>E. faecalis,</italic> and <italic>S. aureus</italic> (both gram<sup>pos</sup>) (<xref ref-type="bibr" rid="bib16">Diekema et al., 2019</xref>; <xref ref-type="bibr" rid="bib53">Mureșan et al., 2018</xref>) were further cultivated for experimental studies. We quantified released ATP over time (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) using a luciferin-luciferase-based assay. A growth-dependent release of ATP was observed in all species, peaking during exponential growth phase (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Cumulative amount of released ATP was quantified using the area under the curve (AUC) of released ATP over time (AUC ATP). ATP release was detected across all assessed species (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). To model these findings in mice, abdominal sepsis was induced using a standardized cecal ligation and puncture (CLP) model (<xref ref-type="bibr" rid="bib21">Dosch et al., 2019</xref>; <xref ref-type="fig" rid="fig1">Figure 1E</xref>). Similar to human samples, Proteobacteria and Firmicutes phyla were predominating (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, see <xref ref-type="fig" rid="fig1">Figure 1B</xref>). In the mouse model, <italic>E. coli</italic> released notably more cumulative ATP compared to <italic>E. faecalis</italic> and <italic>S. aureus</italic> (<xref ref-type="fig" rid="fig1">Figure 1G and H</xref>). The bacterial species assessed in humans and mice (<italic>E. coli</italic>, <italic>E. faecalis</italic>, <italic>S. aureus</italic>) differed on the strain level (sequences deposited, see Data availability statement) confirming that ATP release is strain-specific (<xref ref-type="bibr" rid="bib51">Mempin et al., 2013</xref>). In summary, sepsis-associated bacteria release ATP in a growth-dependent and strain-specific manner. <italic>E. coli,</italic> which is one of the most frequent facultative pathogens in patients with abdominal sepsis, released the highest amount of ATP isolated from a standardized mouse model of abdominal sepsis.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Sepsis-associated bacteria release adenosine triphosphate (ATP) in a growth-dependent manner.</title><p>(<bold>A</bold>) Experimental approach to isolate and cultivate sepsis-associated bacteria from abdominal fluid of patients with abdominal sepsis. (<bold>B</bold>) Bacterial species identified by whole 16S-rRNA Sanger sequencing from abdominal fluid of patients with abdominal sepsis. Three colonies out of 25 could not be identified. (<bold>C</bold>) Measurement of released ATP (M) and growth (OD<sub>600</sub>) over time (hours) from the four sepsis-associated bacteria <italic>E. coli</italic>, <italic>K. pneumoniae</italic>, <italic>E. faecalis,</italic> and <italic>S. aureus</italic> isolated from patients. N=2 independent bacteria cultures. Means and standard deviations are shown. (<bold>D</bold>) Area under the curve (AUC) of released ATP over time (M*hours) of the previously assessed bacteria (cumulative ATP). One-way ANOVA, N=2 independent bacteria cultures. Means and individual values are shown. (<bold>E</bold>) Experimental approach to isolate and cultivate sepsis-associated bacteria from abdominal fluid of mice with abdominal sepsis. (<bold>F</bold>) Bacterial species identified by whole 16S-rRNA Sanger sequencing from abdominal fluid of mice with abdominal sepsis. Seven colonies out of 25 could not be identified. (<bold>G</bold>) Measurement of released ATP (M) and growth (OD<sub>600</sub>) over time (hours) from the three sepsis-associated bacteria <italic>E. coli</italic>, <italic>E. faecalis,</italic> and <italic>S. aureus</italic> isolated from mice. N=2 independent bacteria cultures. Means and standard deviations are shown. (<bold>H</bold>) AUC of released ATP over time (M*hours) of the previously assessed bacteria (cumulative ATP). One-way ANOVA, N=2 independent bacteria cultures. Means and individual values are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Experimental approach to measure released bacterial adenosine triphosphate (ATP) and growth over time.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig1-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Bacterial ATP release is dependent on ATP synthesis at the inner bacterial membrane and correlates with bacterial growth</title><p>After having demonstrated that sepsis-associated bacteria release ATP, we next questioned whether and how ATP release is dependent on ATP generation. ATP synthase and cytochrome oxidases, which are located in the inner bacterial membrane, are key components of ATP generation under aerobic conditions. Therefore, ATP release of the <italic>E. coli</italic> parental strain (PS) was compared to all available mutants of ATP synthase subunits (<italic>ΔatpA</italic>, <italic>ΔatpB</italic>, <italic>ΔatpC</italic>, <italic>ΔatpD</italic>, <italic>ΔatpE</italic>, <italic>ΔatpF</italic>, <italic>ΔatpH</italic>) and cytochrome <italic>bo<sub>3</sub></italic> oxidase subunits (<italic>ΔcyoA</italic>, <italic>ΔcyoB</italic>, <italic>ΔcyoC</italic>, <italic>ΔcyoD</italic>) from the Keio collection (<xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref>; <xref ref-type="bibr" rid="bib89">Yamamoto et al., 2009</xref>). The use of different mutants allows to identify the most relevant subunits influencing ATP release. Also, it allows to identify a possible correlation of bacterial ATP release with growth, which is a function of ATP generation (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib25">Galber et al., 2021</xref>; <xref ref-type="bibr" rid="bib30">Ihssen et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Ivancic et al., 2008</xref>; <xref ref-type="bibr" rid="bib49">Lundin, 2000</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Adenosine triphosphate (ATP) release is dependent on ATP synthesis.</title><p>(<bold>A</bold>) Illustration depicting the location of ATP synthase and cytochrome <italic>bo<sub>3</sub></italic> oxidase in gram<sup>neg</sup> bacteria. (<bold>B</bold>) Measurement of released ATP (M) and growth (OD<sub>600</sub>) over time (hours) from cytochrome <italic>bo<sub>3</sub></italic> oxidase (cyo) and ATP synthase (atp) mutants. The parental strain (PS) was added as a control. N=2 independent bacteria cultures. Means and standard deviations are shown. (<bold>C</bold>) Area under the curve (AUC) of released ATP over time (M*hours) of the previously assessed bacteria (cumulative ATP) is shown individually in the left panel. N=2 independent bacteria cultures. Means and individual values are shown. Means of grouped cyo and atp mutants are compared in the right panel. t-Test. Means and individual values are shown. (<bold>D</bold>) Cumulative ATP (M*hours) and cumulative growth (OD<sub>600</sub>*hours) of all assessed cyo and atp mutants and the PS were plotted against each other. Pearson’s correlation (r) and coefficient of determination (R<sup>2</sup>) of the applied linear model are depicted. 95% confidence level is shown by the black dashed lines.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig2-v1.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 2A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0</ext-link>. Further reproductions must adhere to the terms of this license</license-p></license></permissions></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Peak ATP (M) and peak growth (OD<sub>600</sub>*hours) of all assessed cyo and atp mutants and the PS were plotted against each other.</title><p>Pearson’s correlation (r) and coefficient of determination (R<sup>2</sup>) of the applied linear model are depicted. 95% confidence level is shown by the black dashed lines.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Bacterial growth (OD<sub>600</sub>) and ATP release were measured over time and cumulative ATP release (AUC ATP) was assessed (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). We first noticed that mutations in subunits of ATP synthase, which is the key enzyme of ATP generation, were generally associated with significantly lower cumulative ATP release compared to mutations in cytochrome <italic>bo<sub>3</sub></italic> oxidase subunits (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Therefore, we suspected an interrelation between ATP generation and released ATP (see growth and ATP release curves in <xref ref-type="fig" rid="fig2">Figure 2B</xref>). We determined cumulative growth (AUC growth) in addition to cumulative ATP release and indeed, cumulative ATP release and cumulative growth were positively correlated (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), similar to peak ATP and peak growth (OD<sub>600</sub>) that are positively correlated (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). In summary, ATP release is directly dependent on ATP generation at the inner bacterial membrane. Mutations in subunits of bacterial ATP synthase have a higher impact on ATP generation, growth, and ATP release than mutations in subunits of cytochrome <italic>bo<sub>3</sub></italic> oxidase (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p></sec><sec id="s2-3"><title>Outer bacterial membrane integrity and bacterial death determine bacterial ATP release during growth</title><p>We next focused on the outer membrane by challenging its integrity while leaving ATP generation and the inner membrane intact. For that purpose, we used the <italic>E. coli</italic> porin mutants <italic>ΔompC</italic>, <italic>ΔompF</italic>, <italic>ΔlamB,</italic> and <italic>ΔphoE</italic> (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref>; <xref ref-type="bibr" rid="bib89">Yamamoto et al., 2009</xref>), which have been shown to suffer from impaired outer membrane integrity in varying degrees (<xref ref-type="bibr" rid="bib15">Choi and Lee, 2019</xref>). ATP release and growth were measured over time including <italic>E. coli</italic> PS as baseline and membrane destabilizing EDTA and stabilizing Ca<sup>2+</sup> as additional controls (<xref ref-type="bibr" rid="bib45">Leive, 1968</xref>). Cumulative ATP release (AUC ATP) from the porin mutants were notably different compared to the PS, being lowest in <italic>ΔompC</italic> and highest in <italic>ΔompF</italic> (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Outer membrane integrity and bacterial death determine bacterial adenosine triphosphate (ATP) release during growth.</title><p>(<bold>A</bold>) Illustration depicting the location of outer membrane porins in gram<sup>neg</sup> bacteria. (<bold>B</bold>) Measurement of released ATP (M) and growth (OD<sub>600</sub>) over time (hours) from outer membrane porin mutants. The parental strain (PS) and the PS supplemented with either 1 mM Ca<sup>2+</sup> or 0.5 mM EDTA were added as controls. N=2 independent bacteria cultures. Means and standard deviations are shown. The red line marks the individual peak of ATP release and growth (OD<sub>600</sub>) at that time point. (<bold>C</bold>) Area under the curve (AUC) of released ATP over time (M*hours) of the previously assessed bacteria (cumulative ATP). One-way ANOVA, N=2 independent bacteria cultures. Means and individual values are shown. (<bold>D</bold>) ATP concentration (M) and growth (OD<sub>600</sub>) at the individual peak of ATP release of all assessed outer membrane porin mutants, the PS, and the PS+Ca<sup>2+</sup> (no peak for the EDTA control) were plotted against each other. Pearson’s correlation (<bold>r</bold>) and coefficient of determination (R<sup>2</sup>) of the applied linear model are depicted. 95% confidence level is shown by the black dashed lines. (<bold>E</bold>) Gating strategy to identify added counting beads, live, injured, and dead bacteria. (<bold>F</bold>) Quantitative assessment of injured and dead bacteria, as identified by flow cytometry after 4 hr of culturing (ATP peak) of the PS, <italic>ΔompF</italic> and <italic>ΔompC</italic>. One-way ANOVA followed by Tukey post hoc test, N=4 independent bacteria cultures. Means and individual values are shown. (<bold>G</bold>) ATP concentration (M) after 4 hr of culturing (ATP peak) of the PS, <italic>ΔompF</italic> and <italic>ΔompC</italic>. One-way ANOVA followed by Tukey post hoc test, N=2 independent bacteria cultures. Means and individual values are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig3-v1.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 3A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0</ext-link>. Further reproductions must adhere to the terms of this license</license-p></license></permissions></fig><p>Interestingly, the <italic>ΔompF</italic> mutant had also a very high peak of released ATP (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). We hypothesized that this is because of impaired membrane integrity, resulting in ATP release during growth and potentially bacterial death. Thus, we focused on the individual ATP peaks during growth, which were observed after 4 hr of culturing. There was a strong negative correlation between the individual peak of released ATP (marked by the red line in <xref ref-type="fig" rid="fig3">Figure 3B</xref>) and growth at the same time point (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p><p>We did not interfere with ATP generation at the inner membrane but deliberately challenged the outer membrane and tested therewith if destabilization of the outer membrane integrity is associated with bacterial death. Indeed, outer membrane integrity and bacterial death are significantly increased in <italic>ΔompF</italic> compared to <italic>ΔompC</italic> and the PS after 4 hr (ATP peak) of culturing (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>), akin to the amount of released ATP (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). We conclude from these data that destabilization of the outer bacterial membrane (as observed with the <italic>ΔompF</italic> mutant) results in bacterial death that is associated with ATP release.</p><p>In summary, outer membrane integrity and finally bacterial death notably contribute to the amount of bacterial ATP release during growth.</p></sec><sec id="s2-4"><title>Released bacterial ATP reduces neutrophil counts and impairs survival during abdominal sepsis</title><p>Next, we wanted to investigate the function of bacterial ATP release in vivo. To study this, we transformed the <italic>E. coli</italic> PS with an arabinose-inducible apyrase (PS+pAPY) and compared it to the PS transformed with the empty vector (PS+pEMPTY) (<xref ref-type="bibr" rid="bib61">Proietti et al., 2019</xref>). In this model, ATP released by bacteria is hydrolyzed and consequently depleted by a periplasmic apyrase (<xref ref-type="bibr" rid="bib71">Santapaola et al., 2006</xref>; <xref ref-type="bibr" rid="bib73">Scribano et al., 2014</xref>).</p><p>Indeed, apyrase induction resulted in a significant reduction of ATP release in PS+pAPY, compared to PS+pEMPTY (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A and B</xref>). To test the consequences in vivo, apyrase was induced by arabinose 3 hr before intraabdominal (i.a.) injection into wild type C57Bl/6 mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Thereby ATP release was abrogated in the bacteria cultures that were used for injection (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). In vivo, no difference in ATP levels was detected when ATP was measured directly in the abdominal fluid after 4 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) and 8 hr (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). This is not surprising given that ATP is rapidly hydrolyzed by ectonucleotidases in vivo (<xref ref-type="bibr" rid="bib23">Eltzschig et al., 2012</xref>). After both 4 (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>) and 8 hr (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D and E</xref>), no differences in local or systemic bacterial counts were observed. Yet, despite similar bacterial counts, the survival was significantly higher in the absence of bacterial ATP (PS+pAPY) compared to ATP-generating controls (PS+pEMPTY) after i.a. injection (<xref ref-type="fig" rid="fig4">Figure 4F</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Bacterial adenosine triphosphate (ATP) reduces neutrophil counts and impairs sepsis outcome in vivo.</title><p>(<bold>A</bold>) Experimental approach to determine the local role of bacterial ATP in vivo, intraabdominal (i.a.) injecting parental strain (PS)+pEMPTY or PS+pAPY. (<bold>B</bold>) Measurement of released ATP (<bold>M</bold>) in bacteria culture supernatant immediately before bacteria were i.a. injected. t-Test, N=2 independent bacteria cultures. Means and individual values are shown. (<bold>C</bold>) Measurement of ATP (<bold>M</bold>) in abdominal fluid from mice 4 hr after i.a. injection of bacteria. t-Test, n=5 animals per group of N=2 independent experiments. Means and individual values are shown. (<bold>D</bold>) Quantitative assessment of colony forming units in abdominal fluid and (<bold>E</bold>) blood from mice 4 hr after i.a. injection of bacteria. Wilcoxon rank-sum test, n=5 animals per group of N=2 independent experiments. Means and individual values are shown. No growth for controls was detected. (<bold>F</bold>) Kaplan-Meier curves of mice after i.a. injection of bacteria. Log-rank test, n=10 animals per group. (<bold>G</bold>) Heatmap showing surface marker expression (x-axis), which was used to characterize the different immune cell populations (y-axis). (<bold>H</bold>) Concatenated (n=5 animals for each treatment group, n=3 animals for control group of N=2 independent experiments) and down-sampled images of immune cell populations characterized in the abdominal cavity 4 hr after sham treatment or i.a. injection of bacteria. (<bold>I</bold>) Abundance of neutrophils, small peritoneal macrophages (SPM), and CX3CR1<sup>pos</sup> monocytes in abdominal fluid from mice 4 hr after sham treatment or i.a. injection of bacteria. One-way ANOVA followed by Tukey post hoc test, n=5 animals for each treatment group, n=3 animals for control group of N=2 independent experiments. Means and individual values are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Immune cell characterization 8 hr after intraabdominal (i.a.) injection of bacteria.</title><p>(<bold>A</bold>) Measurement of released adenosine triphosphate (ATP) (<bold>M</bold>) and growth (OD<sub>600</sub>) over time (hours) from parental strain (PS)+pEMPTY and PS+pAPY. n=2 measurements of N=3 independent bacteria cultures. Means and standard deviations are shown. (<bold>B</bold>) Area under the curve (AUC) of released ATP over time (M*hours) of the previously assessed bacteria (cumulative ATP). t-Test, n=2 measurements of N=3 independent bacteria cultures. Means and individual values are shown. (<bold>C</bold>) Measurement of ATP (<bold>M</bold>) in abdominal fluid from mice 8 hr after i.a. injection of bacteria. t-Test, n=5 animals per group of N=2 independent experiments. Means and individual values are shown. (<bold>D</bold>) Quantitative assessment of colony forming units in abdominal fluid and (<bold>E</bold>) blood from mice 8 hr after i.a. injection of bacteria. Wilcoxon rank-sum test, n=5 animals per group of N=2 independent experiments. Means and individual values are shown. No growth for controls was detected. (<bold>F</bold>) Concatenated (n=5 animals for each treatment group, n=3 animals for control group of N=2 independent experiments) and down-sampled images of immune cell populations characterized in the abdominal cavity 8 hr after sham treatment or i.a. injection of bacteria. (<bold>G</bold>) Abundance of neutrophils, small peritoneal macrophages (SPM), and CX3CR1<sup>pos</sup> monocytes in abdominal fluid from mice 8 hr after sham treatment or i.a. injection of bacteria. One-way ANOVA followed by Tukey post hoc test, n=5 animals for each treatment group, n=3 animals for control group of N=2 independent experiments. Means and individual values are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Next, we asked how this difference in bacterial ATP release affects the immune system. Therefore, inflammatory cells in the abdominal cavity were characterized using flow cytometry (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). As expected, a disappearance reaction of large peritoneal macrophages (LPM) was observed after both, <italic>E. coli</italic> PS+pEMPTY and <italic>E. coli</italic> PS+pAPY, i.a. injection compared to sham controls after 4 (<xref ref-type="fig" rid="fig4">Figure 4H</xref>) and 8 hr (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>; <xref ref-type="bibr" rid="bib27">Ghosn et al., 2010</xref>). Such LPM disappearance following abdominal <italic>E. coli</italic> infection is a result of free-floating clots composed of LPM and neutrophils and important for effective pathogen clearance (<xref ref-type="bibr" rid="bib70">Salm et al., 2023</xref>; <xref ref-type="bibr" rid="bib82">Vega-Pérez et al., 2021</xref>; <xref ref-type="bibr" rid="bib92">Zindel et al., 2021</xref>) but not dependent on ATP release according to our data. Interestingly, however, the number of small peritoneal macrophages (SPM) and CX3CR1<sup>pos</sup> monocytes was significantly reduced, whereas neutrophils were significantly increased almost up to 8 hr (<xref ref-type="fig" rid="fig4">Figure 4I</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>) in bacterial ATP-depleted abdominal sepsis (PS+pAPY). This effect is dependent on released bacterial ATP given that no differences in bacterial counts were observed (see <xref ref-type="fig" rid="fig4">Figure 4D and E</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D–E</xref>).</p><p>In summary, ATP released by bacteria suppresses abdominal inflammatory responses and worsened survival in a model of abdominal sepsis.</p></sec><sec id="s2-5"><title>Establishing ATP-loaded OMV as a model system to assess the systemic relevance of bacterial ATP</title><p>ATP is rapidly metabolized in the extracellular space and therefore, the mode of action of released bacterial ATP is limited to the immediate cellular vicinity (<xref ref-type="bibr" rid="bib34">Junger, 2011</xref>). However, the outcome of sepsis is not only dependent on local but also on systemic responses to microorganisms. Therefore, we hypothesized that bacterial ATP has systemic effects as protected cargo in OMV (<xref ref-type="bibr" rid="bib1">Alvarez et al., 2017</xref>). OMV are small (20–300 nm) spherical particles that are released by both gram<sup>neg</sup> and gram<sup>pos</sup> bacteria (<xref ref-type="bibr" rid="bib72">Schwechheimer and Kuehn, 2015</xref>). In gram<sup>neg</sup> bacteria, they bulge off the outer membrane and disseminate throughout the body (<xref ref-type="bibr" rid="bib33">Jang et al., 2015</xref>). They are equipped with typical bacterial surface features lacking the machinery for self-reproduction, and contain DNA, proteins, and metabolites (<xref ref-type="bibr" rid="bib7">Baeza and Mercade, 2021</xref>; <xref ref-type="bibr" rid="bib10">Bitto et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Kulp and Kuehn, 2010</xref>; <xref ref-type="bibr" rid="bib43">Lee et al., 2007</xref>). Therefore, OMV are suited as a systemic delivery system for bacterial ATP. Indeed, recently, ATP has been detected in OMV derived from pathogenic <italic>Neisseria gonorrhoeae</italic>, <italic>Pseudomonas aeruginosa</italic> PAO1, and <italic>Acinetobacter baumannii</italic> AB41 (<xref ref-type="bibr" rid="bib59">Pérez-Cruz et al., 2015</xref>).</p><p>To assess the potential of OMV as ATP carriers, we compared the OMV production from several hypervesiculation <italic>E. coli</italic> mutants (<italic>ΔmlaE</italic>, <italic>ΔmlaA</italic>, <italic>ΔrfaD</italic>, <italic>ΔdegP</italic>, <italic>ΔrodZ</italic>, <italic>ΔnlpI</italic>, <italic>ΔtolB</italic>) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; <xref ref-type="bibr" rid="bib50">McBroom et al., 2006</xref>). The <italic>ΔnlpI</italic> and <italic>ΔtolB</italic> strains showed a 20- and 30-fold increase of OMV when compared with the PS (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). We then assessed ATP release and growth over time from <italic>ΔnlpI</italic>, <italic>ΔtolB,</italic> and the PS, to identify their individual peak of ATP release, and isolated OMV at their individual peak of ATP release and after 24 hr (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). ATP was detected in OMV from all assessed strains at the individual peak of ATP release but only in minimal detectable levels after 24 hr (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The <italic>ΔtolB</italic> OMV isolated after 24 hr were then used as ATP-depleted vehicles. Density gradient ultracentrifugation showed that most <italic>ΔtolB</italic> OMV were of similar density and protein composition (<xref ref-type="fig" rid="fig5">Figure 5D</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). They were equipped with outer membrane ompF but not cytoplasmic ftsZ (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), indicating that they are outer membrane derived. In order to generate OMV with known and constant ATP concentrations, we used electroporation (EP) to load OMV with ATP while empty OMV (<italic>ΔtolB</italic> OMV harvested from 24 hr culture) served as ATP-depleted controls (<xref ref-type="bibr" rid="bib24">Fu et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Lennaárd et al., 2021</xref>). Before and after EP, the OMV size distribution was assessed by nanoparticle tracking analysis and morphology by electron microscopy (<xref ref-type="fig" rid="fig5">Figure 5E</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). OMV were loaded with ATP (<xref ref-type="fig" rid="fig5">Figure 5F</xref>) and over time, the amount of ATP in OMV decreased, especially at physiological (37°C) temperature (<xref ref-type="fig" rid="fig5">Figure 5G</xref>) as opposed to 4°C (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Outer membrane vesicles (OMV) contain adenosine triphosphate (ATP) and can be exploited as a model to assess the systemic relevance of bacterial ATP.</title><p>(<bold>A</bold>) Illustration depicting the location of assessed proteins that lead to a hypervesiculation phenotype if knocked out in the gram<sup>neg</sup> bacterium <italic>E. coli</italic>. (<bold>B</bold>) Relative amount of OMV compared to the parental strain (PS) isolated from growth cultures of the assessed hypervesiculation mutants after 5 hr (exponential growth phase) and O/N (stationary phase). n=2 measurements of N=3 independent bacteria cultures. Means and individual values are shown. (<bold>C</bold>) Absolute quantification of ATP in OMV isolated from growth cultures of the PS, <italic>ΔnlpI</italic> and <italic>ΔtolB</italic> at their individual peak of ATP release and after 24 hr. n=2 measurements of N=3 independent bacteria cultures. Means and individual values are shown. (<bold>D</bold>) Amount of protein (BCA assay) detected in different fractions after density gradient ultracentrifugation. n=2 measurements of the different fractions. 20 µl of <italic>E. coli</italic> growth culture and 20 µl of each fraction were then characterized by Coomassie blue staining and specific detection of outer membrane ompF and cytoplasmic ftsZ. (<bold>E</bold>) Characterization of OMV by nanoparticle tracking analysis (n=5 measurements per sample) and electron microscopy (representative image) before and after electroporation. (<bold>F</bold>) Absolute quantification of ATP in OMV, which were loaded using different strategies. Columns 2–5: different concentrations of ATP incubated for 1 hr at 37°C (passive filling). Columns 6–12: different voltages with fixed settings for resistance (100 Ω) and capacitance (50 µF). N=2–9 independent experiments. Means and standard deviations are shown. (<bold>G</bold>) Relative quantification of ATP in OMV over 24 hr at 37°C after electroporation (0 hr=100%). n=2 measurements of N=3 independent experiments. Means and individual values are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig5-v1.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 5A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0</ext-link>. Further reproductions must adhere to the terms of this license</license-p></license></permissions></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Adenosine triphosphate (ATP) measurement of the parental strain (PS), <italic>ΔnlpI</italic> as well as <italic>ΔtolB</italic> and outer membrane vesicle (OMV) collection and characterization.</title><p>(<bold>A</bold>) Measurement of released ATP (M) and growth (OD<sub>600</sub>) over time (hours) from PS, <italic>ΔnlpI</italic> and <italic>ΔtolB</italic>. OMV collection time points are marked in purple. n=2 measurements of N=3 independent bacteria cultures. Means and standard deviations are shown. (<bold>B</bold>) OMV before and after density gradient ultracentrifugation for 16 hr at 150,000×<italic>g</italic>. (<bold>C</bold>) Statistical parameters of OMV before electroporation as well as ATP-loaded and empty OMV after electroporation. (<bold>D</bold>) Relative quantification of ATP in OMV 16 hr at 4°C after electroporation (0 hr=100%). n=2 measurements of N=3 independent experiments. Means and individual values are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig5-figsupp1-v1.tif"/></fig></fig-group><p>In summary, OMV contain ATP and release ATP at physiological temperatures. To use OMV as an ATP delivery system, empty OMV were loaded using EP.</p></sec><sec id="s2-6"><title>OMV-derived bacterial ATP induces degranulation processes in neutrophils after lysosomal uptake</title><p>OMV are potent inducers of inflammation and sepsis (<xref ref-type="bibr" rid="bib56">Park et al., 2010</xref>; <xref ref-type="bibr" rid="bib57">Park et al., 2013</xref>), which travel throughout the body and are taken up by a variety of cells (<xref ref-type="bibr" rid="bib9">Bittel et al., 2021</xref>; <xref ref-type="bibr" rid="bib37">Kim et al., 2013</xref>; <xref ref-type="bibr" rid="bib44">Lee et al., 2018</xref>). To tests the hypothesis that ATP within OMV mediates systemic effects of invasive bacteria, we injected ATP-loaded and empty OMV i.a. and investigated the resulting inflammation 1 hr after injection (<xref ref-type="fig" rid="fig6">Figure 6A</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Bacterial adenosine triphosphate (ATP) within outer membrane vesicles (OMV) upregulates lysosome-related pathways and degranulation processes in neutrophils.</title><p>(<bold>A</bold>) Experimental approach to determine the systemic role of bacterial ATP in vivo, intraabdominal (i.a.) injecting ATP-loaded or empty OMV. (<bold>B</bold>) Representative microscopic images of cells from the abdominal cavity 1 hr after i.a. injection of either ATP-loaded or empty OMV. OMV: DiI, Nucleus: DAPI, Neutrophils: Ly-6G-FITC. (<bold>C</bold>) Cells from remote organs were isolated 1 hr after i.a. injection of either ATP-loaded or empty OMV. OMV were mainly taken up by neutrophils (except in the spleen, ratio ≈ 1). t-Test with Benjamini-Hochberg correction, n=5 animals per group of N=2 independent experiments. Means and individual values are shown. (<bold>D</bold>) Representative microscopic image of pulmonary neutrophils 1 hr after i.a. injection of either ATP-loaded or empty OMV. OMV co-localize with the endolysosomal compartment. OMV: DiI, Endolysosomal system: LysoTracker Deep Red, Neutrophils: Ly-6G-FITC. (<bold>E</bold>) Pulmonary neutrophils were isolated 1 hr after i.a. injection of ATPγs-loaded or empty OMV, bead-sorted, and RNA sequencing was done. Principal component analysis shows significantly different clustering between neutrophils that took up ATPγs-loaded (NA) or empty OMV (NE). PERMANOVA, n=6 animals in the NE group, n=5 animals in the NA group. Ellipses represent 95% confidence level. (<bold>F</bold>) Volcano plot of RNA sequencing results shows an upregulation of genes mainly in the NA group. Genes classified in either lysosome (LYSO) or neutrophil degranulation pathways (NDG) or both, which were mentioned in the text, were highlighted. (<bold>G</bold>) Heatmap of the lysosome pathway (LYSO) showing the gene expression per sample. (<bold>H</bold>) Heatmap of the neutrophil degranulation pathway (NDG) showing the gene expression per sample.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Uptake of outer membrane vesicles (OMV) by neutrophils.</title><p>Representative images of OMV uptake by neutrophils in the abdominal cavity 1 hr after intraabdominal (i.a.) injection additionally assessed using flow cytometry (ImageStream).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Characterization of local immune response in the abdominal cavity.</title><p>(<bold>A</bold>) Gating strategy to identify large peritoneal macrophages (LPM), small peritoneal macrophages (SPM), and neutrophils in abdominal fluid. (<bold>B</bold>) Abundance of OMV<sup>pos</sup>/(OMV<sup>pos</sup>+OMV<sup>neg</sup>) LPM, SPM, and neutrophils 1 hr after intraabdominal (i.a.) injection of adenosine triphosphate (ATP)-loaded or empty OMV. t-Test with Benjamini-Hochberg correction, n=5 animals per group of N=2 independent experiments. Means and individual values are shown. (<bold>C</bold>) Abundance of LPM, SPM, and neutrophils 1 hr after sham treatment or i.a. injection of either ATP-loaded or empty OMV. One-way ANOVA, n=5 animals for each treatment group, n=3 animals for control group of N=2 independent experiments. Means and individual values are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Assessment of outer membrane vesicle (OMV) uptake by immune cells in remote organs.</title><p>(<bold>A</bold>) Gating strategy to identify total OMV<sup>pos</sup> cells and specifically OMV<sup>pos</sup> neutrophils in blood and remote organs (lung, liver, kidney, and spleen). (<bold>B</bold>) Fraction of OMV<sup>pos</sup>/(OMV<sup>pos</sup>+OMV<sup>neg</sup>) neutrophils 1 hr after intraabdominal (i.a.) injection of adenosine triphosphate (ATP)-loaded or empty OMV. t-Test, n=5 animals per group of N=2 independent experiments. Means and individual values are shown. (<bold>C</bold>) Fraction of % of CD45<sup>pos</sup>live cells 1 hr after intraabdominal (i.a.) injection of adenosine triphosphate (ATP)-loaded or empty OMV including control without OMV injection. t-Test, n=5 animals per group of N=2 independent experiments. Means and individual values are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Assessment of the purity of bead-sorted pulmonary neutrophils.</title><p>Pulmonary neutrophils were isolated 1 hr after i.a. injection of ATPγs-loaded or empty outer membrane vesicle (OMV), bead-sorted and assessed for purity by flow cytometry. A representative image is shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig6-figsupp4-v1.tif"/></fig><fig id="fig6s5" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 5.</label><caption><title>List of significantly different pathways after enrichment analysis of RNA sequencing results.</title><p>Pulmonary neutrophils were isolated 1 hr after intraabdominal (i.a.) injection of ATPγs-loaded or empty outer membrane vesicle (OMV), bead-sorted, and RNA sequencing was done. This resulted in these significantly different pathways between the groups after enrichment analysis. DESeq, n=6 animals in the NE group, n=5 animals in the NA group.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-fig6-figsupp5-v1.tif"/></fig></fig-group><p>In the abdominal fluid, uptake of DiI-stained OMV by leukocytes was independent of ATP cargo (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>) and all major cell populations with phagocytic ability (LPM, SPM, neutrophils) were highly positive for OMV (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A and B</xref>). LPM dramatically decreased, whereas neutrophils increased in response to OMV when compared to sham controls (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>).</p><p>Within 1 hr, the DiI-stained OMV were distributed throughout the body and mainly taken up by neutrophils, with remarkable differences between organs (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3A and B, C</xref>). The highest ratio of OMV<sup>pos</sup> neutrophils compared to all other OMV<sup>pos</sup> cells was observed in the lung in an ATP-independent manner (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Intracellular fate of engulfed OMV is still a matter of discussion but one possibility is the degradation in the endolysosomal compartment (<xref ref-type="bibr" rid="bib8">Bielaszewska et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Juodeikis and Carding, 2022</xref>). We therefore injected DiI-stained OMV i.a. to assess to which membrane compartment OMV co-localize. A strong co-localization with the endolysosomal compartment of pulmonary neutrophils was identified (<xref ref-type="fig" rid="fig6">Figure 6D</xref>).</p><p>To determine what pathways OMV-derived bacterial ATP initiates in neutrophils after uptake into the endolysosomal compartment, pulmonary neutrophils were isolated (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>) for RNA sequencing. Uptake of ATP-loaded OMV resulted in a significantly different transcriptional activity compared to empty OMV (<xref ref-type="fig" rid="fig6">Figure 6E</xref>): The strongest differences were found in lysosomal and neutrophil degranulation pathways (<xref ref-type="fig" rid="fig6">Figure 6F</xref>, <xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5</xref>). In the lysosomal pathway, transcripts for proteins involved in autophagosome-lysosome fusion (Gabarap), endosome to lysosome transport (Hgsnat, Laptm5), or enzymatic cleavage (Capn1, Fuca1, Ctsb, Ctsd, Gba) were significantly higher expressed in response to ATP-loaded OMV when compared to empty OMV (<xref ref-type="fig" rid="fig6">Figure 6F and G</xref>). Furthermore, neutrophil degranulation was significantly increased in response to ATP-loaded OMV as indicated by increased expression of gene transcripts resulting in antibacterial activity (Lyz2, S100a8, Camp) or NETosis (Tlr2, Itgb2) (<xref ref-type="fig" rid="fig6">Figure 6F and H</xref>).</p><p>In summary, OMV are phagocytosed locally by major cell populations with phagocytic ability. Remotely, OMV were mainly taken up by neutrophils, where they co-localize with the endolysosomal compartment. Delivery of ATP by OMV resulted in an upregulation of lysosomal activation and neutrophil degranulation.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we have demonstrated that ATP release is dependent on the respiratory chain located at the inner bacterial membrane. ATP synthase is most likely dominant compared to cytochrome <italic>bo<sub>3</sub></italic> oxidase because of its non-redundant function for ATP generation and bacterial growth. Mutations in one of the cytochrome <italic>bo<sub>3</sub></italic> oxidase subunits cyoA, cyoC, or cyoD could be compensated by another subunit. This is supported by lower ATP release in the cyoB mutant, which harbors all three prosthetic groups of the cytochrome <italic>bo<sub>3</sub></italic> oxidase and is therefore indispensable for proper function (<xref ref-type="bibr" rid="bib78">Tsubaki et al., 2000</xref>). Alternatively, deficiency in the <italic>bo<sub>3</sub></italic>-type oxidase could be partially compensated by <italic>bd</italic>-type oxidases (<xref ref-type="bibr" rid="bib11">Borisov et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Grauel et al., 2021</xref>).</p><p>Instability of the outer bacterial membrane as we have seen for the <italic>ΔompF</italic> mutant (<xref ref-type="bibr" rid="bib15">Choi and Lee, 2019</xref>) is associated with bacterial death and ATP release. It remains unclear whether loss of ATP results directly in bacterial death or bacterial death is the direct result of impaired outer bacterial membrane stability and ATP release is secondary to bacterial death. However, since the inner membrane and ATP generation remains intact and the periplasmic space is considered generally devoid of ATP, the latter seems more likely (<xref ref-type="bibr" rid="bib40">Kulp and Kuehn, 2010</xref>). Previous studies used Sytox/PI staining and microscopy to identify bacterial death and did not identify bacterial death as a relevant source of extracellular ATP during exponential growth (<xref ref-type="bibr" rid="bib29">Hironaka et al., 2013</xref>). Conversely, we used flow cytometry, a quantitatively more sensitive method, and our data demonstrated that impaired membrane integrity and bacterial death are critical for ATP release during growth. Despite low rates of bacterial death during exponential growth (<xref ref-type="bibr" rid="bib38">Koch, 1959</xref>), and a low ratio of dead to live bacteria, the high gradient between intra- and extracellular ATP (approximately 100–1000× higher) might be sufficient to explain the amount of released ATP measured (<xref ref-type="bibr" rid="bib42">Leduc and van Heijenoort, 1980</xref>; <xref ref-type="bibr" rid="bib51">Mempin et al., 2013</xref>).</p><p>ATP was detected within OMV and the concentration of ATP within OMV is sufficient to activate P2-type receptors in lysosomes (<xref ref-type="bibr" rid="bib2">Araujo et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Junger, 2011</xref>). Furthermore, OMV are released in response to environmental stresses like infection and sepsis (<xref ref-type="bibr" rid="bib40">Kulp and Kuehn, 2010</xref>; <xref ref-type="bibr" rid="bib55">Orench-Rivera and Kuehn, 2016</xref>). ATP is likely to activate P2 receptors, which have been shown to be expressed in lysosomes, such as P2X1, P2X3, or P2X4 (<xref ref-type="bibr" rid="bib62">Qureshi et al., 2007</xref>; <xref ref-type="bibr" rid="bib67">Robinson and Murrell-Lagnado, 2013</xref>). OMV can therefore be considered as non-living bacteria-resembling highly inflammatory vesicles (<xref ref-type="bibr" rid="bib33">Jang et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Kulp and Kuehn, 2010</xref>) that effectively distribute ATP throughout the body to activate cells, such as neutrophils, initiating systemic inflammatory responses. Activation of neutrophils in response to ATP-loaded OMV resulted in upregulation of inflammatory, lysosomal, and neutrophil degranulation pathways as well as an upregulation of the apoptosis pathway and genes involved in NETosis by a hitherto unknown mechanism. These pathways explain in part the low neutrophil counts we observed in mice. Such remote degranulation in response to OMV is unlikely to control bacteria at the source of sepsis but rather harmful to host tissues increasing sepsis severity (<xref ref-type="bibr" rid="bib22">Eichelberger and Goldman, 2020</xref>).</p><p>The study has several limitations: Bacterial ATP release is strain specific (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="bibr" rid="bib51">Mempin et al., 2013</xref>). As we focused on the laboratory BW25113 <italic>E. coli</italic> strain, it remains to be elucidated if impaired outer membrane integrity and bacterial death are also of such importance in other gram<sup>neg</sup> or also gram<sup>pos</sup> bacteria. The approach to load OMV with ATP is rather artificial; it is, however, the only way to assure that ATP-loaded and empty OMV only differ in their ATP cargo. OMV have surface antigens and contain DNA, proteins, and other metabolites (<xref ref-type="bibr" rid="bib40">Kulp and Kuehn, 2010</xref>), which are known to elicit inflammation as well. This was controlled using the same OMV as baseline vehicles.</p><p>Several open questions need to be addressed in future projects: It remains to be determined how OMV are physiologically loaded with ATP. Potentially, despite the lack of a transporter, ATP may similarly to eukaryotic cells leak (<xref ref-type="bibr" rid="bib90">Yegutkin et al., 2006</xref>) across the inner membrane into the periplasmic space that lacks the enzymes for ATP generation. Different types of OMV have been described in recent years, e.g., outer-inner membrane vesicles (O-IMV) or explosive OMV (<xref ref-type="bibr" rid="bib35">Juodeikis and Carding, 2022</xref>; <xref ref-type="bibr" rid="bib76">Takaki et al., 2020</xref>; <xref ref-type="bibr" rid="bib77">Toyofuku et al., 2019</xref>; <xref ref-type="bibr" rid="bib79">Turnbull et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">Turner et al., 2015</xref>), which are composed of outer membrane, inner membrane, and cytoplasmic content. The mechanisms, how these types of OMV are generated, could explain that ATP is found within them. However, the <italic>ΔtolB</italic> mutant produces, unlike other tol mutants, only very few O-IMV (0.1–2% of all OMV) (<xref ref-type="bibr" rid="bib58">Pérez-Cruz et al., 2013</xref>; <xref ref-type="bibr" rid="bib64">Reimer et al., 2021</xref>; <xref ref-type="bibr" rid="bib76">Takaki et al., 2020</xref>) and our western blot analysis suggests that our OMV are primarily outer membrane derived. Future studies may address the ATP cargo of the different OMV subgroups.</p><p>OMV are promising diagnostic molecular biomarkers in gram<sup>neg</sup> sepsis (<xref ref-type="bibr" rid="bib52">Michel and Gaborski, 2022</xref>) and it would be of relevance to compare OMV isolated from septic and control patients to assess possible differences in ATP cargo. Furthermore, it remains to be elucidated, which mechanisms lead to low local neutrophil counts. Since ATP is involved in cell death (<xref ref-type="bibr" rid="bib61">Proietti et al., 2019</xref>) as well as in chemotaxis (<xref ref-type="bibr" rid="bib34">Junger, 2011</xref>), increased cell death, impaired infiltration, or a combination of both is possible.</p><p>This study reveals that ATP is released by bacteria during growth because of impaired membrane integrity and bacterial death. ATP is also being released via OMV and therefore acts locally (direct release) and systemically (via OMV). Bacterial ATP reduces neutrophil counts, activates the endolysosomal system, and upregulates neutrophil degranulation, which together increase the severity of abdominal infection and early sepsis. These findings have the potential to lead to the development of novel treatments for abdominal sepsis, e.g., by in vitro generated OMV that modulate neutrophil function via delivery of inhibitors to intracellular purinergic receptors during sepsis.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Human data</title><p>From five patients that underwent revision laparotomy because of abdominal sepsis, swabs were taken from abdominal fluid, streaked on LB agar plates (15 g Agar, 5 g Bacto Yeast Extract, 10 g Bacto Tryptone, 5 g NaCl in 1 l ddH<sub>2</sub>O; Key resources table) and cultivated an/aerobically for 48 hr. The human experimental protocol was approved by the Cantonal Ethics Commission Bern, Switzerland (ethical approval 2017-00573, NCT03554148). Written informed consent was obtained from all patients and the study has been performed in accordance with the Declaration of Helsinki as well as the CONSORT statement.</p></sec><sec id="s4-2"><title>Mouse handling</title><p>Specific pathogen-free C57Bl/6JRccHsd mice (Key resources table) were purchased at the age of 8 weeks from Inotiv (earlier Envigo, the Netherlands) and were housed in ventilated cages in the Central Animal Facility, University of Bern, Switzerland. All experiments were performed in the morning, mice were supplied with a 12 hr light/dark cycle at 22°C and fed ad libitum with chow and water. To minimize cage effects, we mixed mice over several cages and therefore only used female mice. All animal procedures were carried out in accordance with the Swiss guidelines for the care and use of laboratory animals as well as in accordance with the ARRIVE guidelines and were approved by the Animal Care Committee of the Canton of Bern (Switzerland) under the following number: BE41/2022.</p></sec><sec id="s4-3"><title>CLP sepsis model</title><p>To isolate bacteria from mice with abdominal sepsis, CLP was performed as described elsewhere with some minor modifications (<xref ref-type="bibr" rid="bib66">Rittirsch et al., 2009</xref>). In brief, mice were anesthetized s.c. injecting (3 µl/g body weight) a mixture of fentanyl (0.05 mg/ml), dormicum (5 mg/ml), and medetor (1 mg/ml) and were then shaved and disinfected with Betadine. Mid-line laparotomy was performed (approximately 1 cm) and the cecum was exposed. The proximal one third of the cecum was ligated with Vicryl 4-0 (Ethicon, cat# V1224H) and perforated with a 23 G needle. The cecum was returned to the abdominal cavity and the laparotomy was sutured continuously in two layers with prolene 6-0 (Ethicon, cat# MPP8697H). At the end, the antidote (naloxone [0.1 mg/ml], revertor [5 mg/ml], temgesic [0.3 mg/ml]) was s.c. injected (9 µl/g body weight). A semiquantitative score sheet was used to predict animal postoperative well-being. Mice were evaluated every 4 hr according to the following criteria: appearance, level of consciousness, activity, response to stimulus, eye shape, respiratory rate, and respiratory quality and analgesia was applied if necessary. After 10 hr, abdominal fluid was collected, spread on LB agar plates, and cultivated an/aerobically for 48 hr.</p></sec><sec id="s4-4"><title>Whole 16S-rRNA Sanger sequencing</title><p>Twenty-five colonies cultivated from abdominal fluid of patients and mice each described above were randomly picked and collected in separate sterile Eppendorf tubes and resuspended in 1 ml of sterile PBS. Each sample was centrifuged for 5 min at 20,000×<italic>g</italic> and washed once with 1 ml sterile PBS. The pellet was resuspended in 20 µl of sterile PBS and samples were incubated 5 min at 100°C. 1 µl was used for PCR using GoTaq G2 Green Master Mix (Key resources table) and the following primers (Key resources table) at a final concentration of 0.2 µM:</p><list list-type="simple"><list-item><p>-fD1: 5’-AGA-GTT-TGA-TCC-TGG-CTC-AG-3’</p></list-item><list-item><p>-fD2: 5’-AGA-GTT-TGA-TCA-TGG-CTC-AG-3’</p></list-item><list-item><p>-rP1: 5’-ACG-GTT-ACC-TTG-TTA-CGA-CTT-3’</p></list-item></list><p>PCR conditions were as follows: Initial 5 min at 94°C for denaturation, followed by 35 cycles of 1 min denaturation at 94°C, 1 min annealing at 43°C, and 2 min extension at 72°C, with a final extension for 10 min at 72°C. This resulted in a PCR product of optimally ~1400–1500 bp. 20 µl PCR product were run on 2% agarose gel for 90 min, cut out and purified using QIAquick Gel Extraction Kit (Key resources table). The amplicon concentration was measured using nanodrop (Thermo Fisher Scientific) and Sanger sequencing was done by Microsynth.</p></sec><sec id="s4-5"><title>Quantification of released bacterial ATP</title><p>Bacteria were aerobically grown in 20 ml LB medium (5 g Bacto Yeast Extract, 10 g Bacto Tryptone, 5 g NaCl in 1 l ddH<sub>2</sub>O; Key resources table) overnight (O/N) (16 hr/37°C/200 rpm) and 0.25 ml of O/N culture were diluted in 100 ml fresh LB medium. Up to 24 hr, 0.25 ml bacteria culture were taken at several time points for growth assessment (OD<sub>600</sub>) and 1 ml was taken for ATP quantification. OD<sub>600</sub> was measured using a Tecan Spark spectrophotometer. The 1 ml sample for ATP quantification was centrifuged for 5 min at 16,000×<italic>g</italic>, the supernatant was filtered through a 0.2 µm syringe filter and stored at –80°C. ATP was quantified using a luciferin-luciferase-based assay according to the manufacturer’s protocol (ATP Kit SL, Key resources table) and bioluminescence was measured using a Tecan Spark spectrophotometer. In <xref ref-type="fig" rid="fig3">Figure 3</xref>, LB medium was supplemented with 1 mM calcium or 0.5 mM EDTA for the controls.</p></sec><sec id="s4-6"><title>Absolute quantification of bacteria and assessment of viability</title><p>Growth culture was set up as described above and after 4 hr (ATP peak), samples were taken to quantify bacteria and assess viability. Bacteria were diluted in PBS and stained using the Cell Viability Kit with BD Liquid Counting Beads (Key resources table) according to the manufacturer’s protocol. In brief, 100 µl of diluted bacterial growth culture was stained with 1 µl TO dye, 1 µl PI dye, and 10 µl of counting beads were added. The sample was acquired on a CytoFlex S (Beckman Coulter), setting the thresholds for the TO- and the PI-channel to 1000 and analysis was done with FlowJo software (Key resources table). Bacterial biomass was calculated to bacteria/ml culture according to the manufacturer’s protocol.</p></sec><sec id="s4-7"><title>Transformation of <italic>E. coli</italic> PS</title><p>The Keio collection (Key resources table) <italic>E. coli</italic> PS was aerobically grown in LB medium O/N (16 hr/37°C/200 rpm). 0.5 ml O/N culture was diluted in 35 ml fresh LB medium and incubated until OD<sub>600</sub> was 0.35–0.45. Cultures were chilled in ice-water and washed two times with ice-cold 20 ml ultrapure water (Thermo Fisher Scientific, cat# 10977035) (20 min/4°C/3200×<italic>g</italic>). The supernatant was carefully decanted, and the bacterial pellet was gently resuspended by pipetting (no vortex). After the final wash, the pellet was resuspended in 240 µl ice-cold ultrapure water and kept on ice until EP. 80 µl of ice-cold bacterial cells were mixed with 1 µl plasmid (pBAD28==pEMPTY or pHND10==pAPY, 100–200 ng, Key resources table) in chilled 0.1 cm cuvettes (Bio-Rad, cat# 1652089) and immediately electroporated (voltage = 1.8 kV, capacitance = 25 µF, resistance = 200 Ω). Directly after EP, 1 ml of warm LB medium was added to the cuvette, bacteria were transferred to a tube containing 10 ml pre-warmed LB medium and cultivated for 1 hr at 37°C. Then, bacteria were dispersed on LB agar plates supplemented with ampicillin (100 µg/ml) and incubated at 37°C. The next day, three colonies were picked, streaked on a new ampicillin supplemented LB agar plate, and incubated for 24 hr. The following day, two cryostocks were made from single colonies in LB medium supplemented with 20% glycerol.</p></sec><sec id="s4-8"><title>Bacteria injection sepsis model</title><p>The Keio collection (Key resources table) <italic>E. coli</italic> PS transformed with either pEMPTY or pAPY was aerobically grown O/N (16 hr/37°C/200 rpm) in 20 ml LB medium supplemented with ampicillin (100 µg/ml). PS+pEMPTY and PS+pAPY were washed with PBS (20 min/22°C/3200×<italic>g</italic>) and resuspended in 20 ml fresh LB medium supplemented with ampicillin (100 µg/ml). To induce the apyrase, L-arabinose (0.03%, Sigma-Aldrich, cat# A3256-25G) was added. After 3 hr, bacteria were washed, resuspended in PBS supplemented with L-arabinose (0.03%) and 2×10<sup>9</sup> colony forming units were injected i.a. ATP in bacteria cultures and in the abdominal fluid were assessed using the same assay as described above (ATP Kit SL, Key resources table). Mice were evaluated for postoperative well-being every 4 hr as described above. After 4 and 8 hr and when the score reached specific criteria (for the survival experiment), animals were sacrificed using pentobarbital (150 mg/kg body weight) followed by organ collection.</p></sec><sec id="s4-9"><title>Collection of abdominal fluid, blood, and organs</title><p>After pentobarbital injection, the mice were placed on a surgical tray, fixed, the abdomen was shaved, the abdominal skin was disinfected with Betadine and the skin (but not peritoneum) was cut. Abdominal cells were isolated as described elsewhere with some modifications (<xref ref-type="bibr" rid="bib63">Ray and Dittel, 2010</xref>). In brief, a 22 G peripheral IV catheter was inserted into the abdominal cavity through the peritoneum. The abdominal cavity was flushed two times with 5 ml MACS buffer (PBS supplemented with 3% FBS [Gibco, cat# 10500-064], 2% HEPES [Sigma-Aldrich, cat# H0887-100ml], and 2 mM EDTA [Sigma-Aldrich, cat# E5134-500G]). The first 5 ml were used to flush the upper abdomen under pressure, and the second 5 ml, to flush the lower abdomen under pressure. Part of the aspirated fluid was used for aerobic plating, if needed, and the rest was centrifuged for 5 min at 700×<italic>g</italic> to pellet the abdominal cells for various downstream applications. To collect blood, the peritoneum was opened. 300 µl blood was collected from the inferior vena cava using a 22 G peripheral IV catheter and a 1 ml syringe, which was prefilled with 30 µl 2 mM EDTA. Before organ collection (lungs, liver, kidney, and spleen), the mouse was flushed with 5 ml PBS. Organs were excised and used for downstream processing.</p></sec><sec id="s4-10"><title>Digestion of organs and preparation of single-cell suspension</title><p>Harvested organs were digested (Key resources table; kidney and lungs: 1 mg/ml Col I+1 mg/ml Col IV+1 mg/ml Col D+0.1 mg/ml DNase I in DMEM [Gibco, cat# 31966-047]+3% FBS for 30 min; liver: 1 mg/ml Col IV+0.1 mg/ml DNase I in DMEM+3% FBS for 20 min) at 37°C with a spinning magnet or gently pushed through a 100 µm mesh (spleen). After washing with MACS buffer (5 min/4°C/700×<italic>g</italic>), erythrocytes were lysed using self-made RBC buffer (90 g NH<sub>4</sub>Cl, 10 g KHCO<sub>3</sub>, 370 mg EDTA in 1 l ddH<sub>2</sub>O for 10× stock). Cells were washed again and stained as described below.</p></sec><sec id="s4-11"><title>Staining of cells and flow cytometry</title><p>First, viability dye (Key resources table) and Fc-block (Key resources table) were diluted in PBS and cells were incubated for 20 min at 4°C in the dark. Cells were washed with MACS buffer and surface staining was done with the listed antibody cocktail:</p><list list-type="simple"><list-item><p>(Key resources table: Ly-6G FITC, Ly-6C PerCP-Cy5.5 or Ly-6C PE-Cy7, CD11b APC, CD206 AF700, CD11c APC-eFluor780, CD45 efluor450 or CD45 APC-Cy7, CD19 Super Bright 600, CD3 BV605, NK1.1 BV605, CCR2 BV650, I-A/I-E BV711, CX3CR1 BV785, Siglec F PE, FcεR1α PE/Dazzle 594, CD115 PE-Cy7, F4/80 BUV395)</p></list-item></list><p>for 20 min at 4°C in the dark. Cells were washed again and resuspended in MACS buffer for acquisition on an LSR-Fortessa (BD Biosciences). Analysis was done with FlowJo software (Key resources table) and OMIQ web-based analysis platform (<ext-link ext-link-type="uri" xlink:href="https://www.omiq.ai/">https://www.omiq.ai/</ext-link>). To preserve the global structure of abdominal cell populations, uniform manifold approximation and projection was used as dimensionality reduction technique and cell populations were defined using FlowSOM clustering algorithm (<xref ref-type="bibr" rid="bib81">Van Gassen et al., 2015</xref>).</p></sec><sec id="s4-12"><title>Absolute quantification of bacteria by plating</title><p>To count bacteria in isolated abdominal fluid, blood, or growth cultures, serial dilutions were done (1 to 1:100,000) and 50 µl of each dilution was streaked on LB agar plates and aerobically incubated. Plates which had between 20 and 200 colony forming units were used for quantification.</p></sec><sec id="s4-13"><title>Collection of OMV and ATP measurement of OMV</title><p><italic>E. coli</italic> PS or hypervesiculation mutants from the Keio collection were grown in LB medium for 5 hr, O/N (16 hr) or 24 hr at 37°C and 200 rpm. Bacteria cultures were then centrifuged (20 min/4°C/3200×<italic>g</italic>) to pellet bacteria. The supernatant was filtered through a 0.45 µm PES filter (Key resources table) and ultracentrifuged (1.5 hr/4°C/150,000×<italic>g</italic>) to pellet OMV. When ATP within OMV was measured, OMV were washed in PBS and directly stored at –80°C. ATP was quantified using a luciferin-luciferase-based assay according to the manufacturer’s protocol (Microbial ATP Kit HS, Key resources table) and bioluminescence was measured using Tecan Spark spectrophotometer.</p><p>If OMV were used for characterization or i.a. injection, first ultracentrifugation was followed by a density gradient ultracentrifugation using OptiPrep (Iodixanol, STEMCELL Technologies, cat# 07820). OMV were resuspended in 50% OptiPrep and OptiPrep gradient (10%, 20%, 30%, 40%, 45%, 50%) was made in underlay technique starting with the 10% layer. Samples were ultracentrifuged (16 hr/4°C/150,000×<italic>g</italic>) and six fractions (fractions 1, 2, 3a, 3b, 4, and 5) were defined. Fractions were washed separately with PBS (1.5 hr/4°C/150,000×<italic>g</italic>) and the amount of OMV was determined measuring protein concentration using BCA assay according to the manufacturer’s protocol (Thermo Fisher Scientific, cat# 23227). For experiments, only OMV from fraction 3 were used, which were washed with PBS (1.5 hr/4°C/150,000×<italic>g</italic>), resuspended in PBS, and stored at –80°C until further processing.</p></sec><sec id="s4-14"><title>EP and staining of OMV</title><p>If EP and staining of OMV was performed, OMV were thawed, pelleted (1.5 hr/4°C/150,000×<italic>g</italic>), the pellet was resuspended in 720 µl EP buffer (500 mM sucrose and 1 ml glycerol in 10 ml ultrapure water) and kept on ice. This suspension was mixed with either 80 µl EP buffer (control) or 80 µl 10 mM ATP (or ATPγs for RNA sequencing experiment) (Key resources table), filled in chilled 0.4 mm EP cuvettes (Bio-Rad, cat# 1652088) and immediately electroporated (voltage = 1100 V, capacitance = 50 µF, resistance = 100 Ω). After EP, the OMV were 1:1 diluted in warm PBS and kept at 37°C for 20 min. DiI (Key resources table) was added 1:100 to the sample during the incubation time. OMV suspension was then washed with PBS (1.5 hr/4°C/150,000×<italic>g</italic>).</p></sec><sec id="s4-15"><title>OMV injection sepsis model</title><p>After the final wash in PBS (see above), OMV were resuspended in NaCl 0.9% and filtered through a 0.45 µm centrifuge filter tube (Sigma-Aldrich, cat# CLS8162-96EA). The final OMV suspension was quantified using a BCA assay. 25 µg of either ATP-loaded OMV or empty OMV were i.a. injected and mice were evaluated as described above. After 1 hr, the animal was sacrificed using pentobarbital followed by organ collection. Tissue digestion and flow cytometry was done as described above.</p></sec><sec id="s4-16"><title>Assessment of ATP release by OMV</title><p>OMV were electroporated as described above. After washing in PBS (1.5 hr/4°C/150,000×<italic>g</italic>), the OMV pellet was resuspended in 6 ml warm PBS and incubated at 37°C. At baseline, after 1, 3, 5, 10, and 24 hr, 1 ml was taken and washed with PBS (1.5 hr/4°C, 150,000×<italic>g</italic>). The OMV pellet was then resuspended in 200 µl PBS to assess protein concentration using a BCA assay, and ATP in OMV was quantified using a luciferin-luciferase-based assay according to the manufacturer’s protocol (Intracellular ATP Kit HS, Key resources table). Bioluminescence was measured using a Tecan Spark spectrophotometer.</p></sec><sec id="s4-17"><title>SDS-PAGE, protein staining, and western blot</title><p>20 µl of diluted <italic>E. coli</italic> culture and 20 µl of the different OMV fractions (except fraction 1, since no protein could be detected) were diluted 1:1 with Laemmli/βME (Laemmli buffer solution containing 5% β-mercaptoethanol). The mixture was heated at 100°C for 5 min, shortly centrifuged at 13,000 rpm and loaded on Mini-PROTEAN TGX Gels (Bio-Rad, cat# 4561094). Bio-Rad marker (6 µl) was added to one well and the gel was run at 100 V for 1.5 hr. The gel was then either directly stained with Coomassie blue or transferred to a membrane.</p><p>Coomassie blue staining was done as follows: The gel was washed in ddH<sub>2</sub>O and the staining solution (Coomassie blue 0.1%, 40% ethanol, 10% acetic acid) was heated for 15 s in the microwave. Warm staining solution was added to the gel and gently shaken for 15 min. Then, staining solution was removed, and the gel was washed with ddH<sub>2</sub>O. Destaining solution (10% ethanol, 7.5% acetic acid) was added for 1 hr, exchanged and left O/N.</p><p>To transfer the proteins to a membrane, iBlot2 (Invitrogen) was used. Membranes were then blocked with 4% milk/PBS for 1 hr. FtsZ-antibody (1:200, Key resources table) and ompF-antibody (1:500, Key resources table) were added and incubated O/N at 4°C. The next day, membranes were washed with PBS Tween (PBST, 0.05%) three times for 5 min. Secondary fluorescent antibody was then added in milk (1:10,000, Key resources table) and membrane was incubated for 1 hr. The membrane was washed again with PBST three times for 5 min and then scanned using a Licor Odyssey.</p></sec><sec id="s4-18"><title>Nanoparticle tracking analysis</title><p>Size distribution of OMV was analyzed using the NanoSight NS300 Instrument (Malvern Panalytical, 405 nm laser) according to the manufacturer’s protocols. OMV were resuspended in PBS and serial dilutions (1 to 1:100,000) were used to find suitable concentrations. Each experimental sample was analyzed five times. PBS was used to flush the system between the samples and to assess background. For each sample, the relative amount of OMV and the OMV size was recorded, which resulted in a size distribution curve. NTA 2.3 software was used to analyze the data and the following script was used for acquisition (<xref ref-type="bibr" rid="bib26">Gheinani et al., 2018</xref>): SETTEMP 25; CAMERAON; CAMERAGAIN 12; CAMERALEVEL 11; REPEATSTART; SYRINGLOAD 100; DELAY 10; SYRINGSTOP; DELAY 15; CAPTURE 60; DELAY 1; <bold>REPEAT 4</bold>; SETTEMP OFF; PROCESSINGLESETTING; EXPORTRESULTS.</p></sec><sec id="s4-19"><title>Electron microscopy negative staining</title><p>For imaging of negatively stained samples, 5 µl of OMV suspension were adsorbed on glow discharged carbon-coated 400 mesh copper grids (Plano) for 1–5 min. After washing the grids three times by dipping in ultrapure water, the grids were stained with 2% uranyl acetate solution (Electron Microscopy Science) in water for 45 s. The excess fluid was removed by gently pushing the grids sideways onto filter paper. The grids were then examined with an FEI Tecnai Spirit transmission electron microscope at 80 kV, which was equipped with a Veleta TEM CCD camera (Olympus).</p></sec><sec id="s4-20"><title>Immunofluorescent microscopy</title><p>One hour after i.a. injection of DiI-stained OMV, lungs were digested as described above. Single-cell suspension was either fixed and imaged or live cells were imaged. For the fixed approach, single-cell suspension was immunolabeled with FITC-tagged anti-Ly-6G (Key resources table) at 1:100 dilution for 20 min at 4°C in the dark to distinguish neutrophils. Cells were washed once with PBS and applied onto glass slides using Cytospin (Thermo Shandon) for 5 min (1800 rpm). Slides were air-dried for 2 min, washed with PBS, and fixed using 4% paraformaldehyde solution for 10 min. Cell nuclei were stained with DAPI (Key resources table) at 1:5000 concentration in IF buffer (0.25% BSA, 0.1% Triton X-100 in PBS) for 1.5 hr at room temperature in the dark. After washing 3×5 min with IF buffer, the slides were covered and sealed with nail polish.</p><p>If live cells were imaged, single-cell suspension was concurrently immunolabeled and stained with Hoechst 33342 (Key resources table) at 1:1000 dilution for cell nuclei, FITC-tagged anti-Ly-6G (Key resources table) at 1:100 dilution for neutrophils and LysoTracker Deep Red (Key resources table) at 1:1000 dilution for lysosomes for 30 min at 37°C in the dark. Cells were washed with MACS buffer and immediately imaged.</p><p>Fluorescence images were taken using either a Zeiss LSM710 or a Zeiss LSM980 inverted confocal laser scanning microscope equipped with a ×63 (NA1.4) oil immersion objective. Detector wavelength cutoffs were set to minimize signal crosstalk between fluorophores.</p></sec><sec id="s4-21"><title>RNA isolation from pulmonary neutrophils</title><p>One hour after OMV i.a. injection, lungs were digested as described above. One animal had to be excluded, since the surgical time point has been missed. Neutrophils were isolated from single-cell suspension using Streptavidin MicroBeads (Miltenyi Biotec, cat# 130-048-101) according to the manufacturer’s protocol. In brief, cells were counted and incubated with a biotinylated anti-mouse Ly-6G antibody (Key resources table) for 20 min at 4°C. After washing, Streptavidin MicroBeads were added and incubated for 20 min at 4°C. After washing, a MidiMACS separator (Miltenyi Biotec, cat# 130-042-302) together with an LS column (Miltenyi Biotec, cat# 130-042-401) was used to isolate neutrophils and purity of positively selected neutrophils as well as unlabeled cells was assessed by flow cytometry (Key resources table: Ly-6C PE-Cy7, CD11b APC). Neutrophils were pelleted, and supernatant was removed by pipetting. Neutrophils were snap-frozen and stored at –80°C. RNA was isolated directly from frozen neutrophils pellets using Promega ReliaPrep RNA Cell Miniprep System (Key resources table) according to the manufacturer’s protocol and quality was assessed using Bioanalyzer and RNA 6000 Nano Kit (RQN 5.8–9.6, median 7.55). Samples were snap-frozen and stored at –80°C until further processing by the Next Generation Sequencing Platform, University of Bern, <ext-link ext-link-type="uri" xlink:href="https://www.ngs.unibe.ch/">https://www.ngs.unibe.ch/</ext-link>.</p></sec><sec id="s4-22"><title>RNA sequencing</title><p>RNA sequencing libraries were prepared using Lexogen CORALL total RNA-seq library kit according to the manufacturer’s protocol, which includes an rRNA depletion step. Sequencing was performed on an Illumina NovaSeq6000 SP flow cell, 2×50 cycles.</p><sec id="s4-22-1"><title>Alignment and quantification</title><p>The resulting fastq files were quality controlled using fastqc v0.11.9 (<xref ref-type="bibr" rid="bib6">Babraham Bioinformatics, 2024</xref>). Forward R1 reads were debarcoded by moving the first 12 nucleotides on the 5' end to the name of the read via fastp v0.19.5 (<xref ref-type="bibr" rid="bib14">Chen et al., 2018</xref>). The alignment was performed with STAR v2.7.10a_alpha_220818 (<xref ref-type="bibr" rid="bib20">Dobin et al., 2013</xref>). First, a genome index was generated from the mouse reference genome GRCm39 ENSEMBL v108. Second, the reads were then aligned to the reference using STAR with default parameters. Gene read counts were quantified using featureCounts from subread v2.0.1 using the mm108 GTF annotation with default parameters (<xref ref-type="bibr" rid="bib47">Liao et al., 2014</xref>).</p></sec><sec id="s4-22-2"><title>Data visualization</title><p>The data from the read count matrix was normalized to reads per million and log-transformed, x → log(1+x). The resulting data was used for principal component analysis, which was performed with the R function <italic>prcomp</italic> and visualized with a custom script using ggplot2 (<xref ref-type="bibr" rid="bib85">Wickham, 2016</xref>).</p></sec><sec id="s4-22-3"><title>Differential gene expression</title><p>Differentially expressed genes were computed using the R package DESeq2 (<xref ref-type="bibr" rid="bib48">Love et al., 2014</xref>).</p></sec><sec id="s4-22-4"><title>Pathway enrichment analysis</title><p>The differentially expressed genes obtained from DESeq2 with an adjusted p-value below 0.01 were uploaded to Metascape for pathway analysis on December 5, 2023 (<xref ref-type="bibr" rid="bib91">Zhou et al., 2019</xref>).</p></sec><sec id="s4-22-5"><title>Heatmaps</title><p>The lists of genes of the pathways of interest were obtained from genome.jp for the KEGG pathways and using the R function <italic>gconvert</italic> from the R package gprofiler2 otherwise (<xref ref-type="bibr" rid="bib39">Kolberg and Raudvere, 2023</xref>). The log-transformed data was used and the heatmaps were done with the heatmap.2 function of the R package gplots with the hierarchical cluster method ‘complete’ using Pearson’s correlation distance (<xref ref-type="bibr" rid="bib83">Warnes et al., 2022</xref>).</p></sec><sec id="s4-22-6"><title>Volcano plot</title><p>The volcano plots were performed with the R package ggplot2 and a custom R script (<xref ref-type="bibr" rid="bib85">Wickham, 2016</xref>).</p></sec></sec><sec id="s4-23"><title>Statistical analysis</title><p>Descriptive statistics and statistical tests were performed using Prism software (Key resources table) or R and RStudio (Key resources table). For differences between two groups a t-test was applied when data was normally distributed (parametric). Otherwise, a Wilcoxon rank-sum test was used (nonparametric). For differences between more than two groups, a one-way ANOVA followed by a Tukey post hoc test (parametric), or a Kruskal-Wallis test followed by a pairwise Wilcoxon rank-sum test with Benjamini-Hochberg correction (nonparametric) was used. For survival analyses, a log-rank test was used. No one-tailed tests were used. No method was used to predetermine experimental sample sizes. A linear model and the correlation between ATP and OD<sub>600</sub> in <xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref> were computed using the R functions <italic>lm</italic> and <italic>cor.test</italic> with the following parameters:</p><p>stats::cor.test(<italic>data</italic>$<italic>variable</italic>ATP, <italic>data</italic>$<italic>variable</italic>growth, alternative = &quot;two.sided&quot;, method = &quot;pearson&quot;) summary(stats::lm(<italic>variable</italic>ATP~<italic>variable</italic>growth, data = <italic>data</italic>)).</p><p>p&lt;0.05 (<italic>P</italic>==padj, when correction for multiple testing was necessary) was considered significant in all statistical analyses unless stated otherwise in the figure legend. Significant differences are in <italic>italic</italic>.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Data curation, Software, Formal analysis, Visualization</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Data curation, Software, Writing - original draft</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con8"><p>Resources, Funding acquisition, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>NCT03554148.</p></fn><fn fn-type="other"><p>The human experimental protocol was approved by the Cantonal Ethics Commission Bern, Switzerland (ethical approval 2017-00573, NCT03554148). Written informed consent was obtained from all patients and the study has been performed in accordance with the Declaration of Helsinki as well as the CONSORT statement.</p></fn><fn fn-type="other"><p>All animal procedures were carried out in accordance with the Swiss guidelines for the care and use of laboratory animals as well as in accordance with the ARRIVE guidelines and were approved by the Animal Care Committee of the Canton of Bern (Switzerland) under the following number: BE41/2022.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-96678-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>RNA sequencing data has been deposited in Gene Expression Omnibus (GEO) under the accession code GSE272296. In addition, all raw data, metadata and code are publicly available at BORIS Portal of the University of Bern under a CC-BY licence: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.48620/418">https://doi.org/10.48620/418</ext-link>.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Spari</surname><given-names>D</given-names></name><name><surname>Schmid</surname><given-names>A</given-names></name><name><surname>Sánchez-Taltavull</surname><given-names>D</given-names></name><name><surname>Murugan</surname><given-names>S</given-names></name><name><surname>Keller</surname><given-names>K</given-names></name><name><surname>Ennaciri</surname><given-names>N</given-names></name><name><surname>Salm</surname><given-names>L</given-names></name><name><surname>Stroka</surname><given-names>D</given-names></name><name><surname>Beldi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Released Bacterial ATP Shapes Local and Systemic Inflammation during Abdominal Sepsis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272296">GSE272296</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Beldi</surname><given-names>G</given-names></name><name><surname>Keller</surname><given-names>KA</given-names></name><name><surname>Sánchez Taltavull</surname><given-names>D</given-names></name><name><surname>Murugan</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>AB</given-names></name><name><surname>Spari</surname><given-names>D</given-names></name><name><surname>Ennaciri</surname><given-names>NS</given-names></name><name><surname>Salm</surname><given-names>L</given-names></name><name><surname>Keogh-Stroka</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Released Bacterial ATP Shapes Local and Systemic Inflammation during Abdominal Sepsis</data-title><source>BORIS Portal</source><pub-id pub-id-type="doi">10.48620/418</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We are grateful for the technical and financial support of the Inselspital, the DBMR, and our laboratory. A special thanks goes to Dana Leuenberger and Isabel Büchi for their support with the animal experiments and microscopy. We also want to thank the Microscopy Imaging Center (MIC) of the University of Bern for their assistance in sample preparation and imaging on the electron microscope. We want to thank Prof. Dr. Fabio Grassi and his group for providing us with the pBAD28 and pHND10 plasmids. We also want to thank Prof. Dr. Siegfried Hapfelmeier, Dr. Olivier Schären, and Prof. Dr. Torsten Seuberlich for their extremely helpful scientific support. We want to thank Prof. Dr. Andrew Macpherson for supporting us with his expertise and providing us with the Keio collection. Finally, we want to thank Prof. Dr. Joel Zindel and Dr. Felix Baier for their critical contributions and ideas to complete this project. Figures were created using<ext-link ext-link-type="uri" xlink:href="https://biorender.com/"> BioRender.com</ext-link>.</p><p>This work was supported by the Swiss National Science Foundation (No.: 166594) to GB.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>CL</given-names></name><name><surname>Corradi</surname><given-names>G</given-names></name><name><surname>Lauri</surname><given-names>N</given-names></name><name><surname>Marginedas-Freixa</surname><given-names>I</given-names></name><name><surname>Leal Denis</surname><given-names>MF</given-names></name><name><surname>Enrique</surname><given-names>N</given-names></name><name><surname>Mate</surname><given-names>SM</given-names></name><name><surname>Milesi</surname><given-names>V</given-names></name><name><surname>Ostuni</surname><given-names>MA</given-names></name><name><surname>Herlax</surname><given-names>V</given-names></name><name><surname>Schwarzbaum</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamic regulation of extracellular ATP in <italic>Escherichia coli</italic></article-title><source>The Biochemical Journal</source><volume>474</volume><fpage>1395</fpage><lpage>1416</lpage><pub-id pub-id-type="doi">10.1042/BCJ20160879</pub-id><pub-id pub-id-type="pmid">28246335</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araujo</surname><given-names>MEG</given-names></name><name><surname>Liebscher</surname><given-names>G</given-names></name><name><surname>Hess</surname><given-names>MW</given-names></name><name><surname>Huber</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lysosomal size matters</article-title><source>Traffic</source><volume>21</volume><fpage>60</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1111/tra.12714</pub-id><pub-id pub-id-type="pmid">31808235</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Arbizu</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>pairwiseAdonis</data-title><version designator="cb190f7">cb190f7</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/pmartinezarbizu/pairwiseAdonis">https://github.com/pmartinezarbizu/pairwiseAdonis</ext-link></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atarashi</surname><given-names>K</given-names></name><name><surname>Nishimura</surname><given-names>J</given-names></name><name><surname>Shima</surname><given-names>T</given-names></name><name><surname>Umesaki</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Onoue</surname><given-names>M</given-names></name><name><surname>Yagita</surname><given-names>H</given-names></name><name><surname>Ishii</surname><given-names>N</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Honda</surname><given-names>K</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>ATP drives lamina propria T(H)17 cell differentiation</article-title><source>Nature</source><volume>455</volume><fpage>808</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1038/nature07240</pub-id><pub-id pub-id-type="pmid">18716618</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Ara</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Okumura</surname><given-names>Y</given-names></name><name><surname>Baba</surname><given-names>M</given-names></name><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Tomita</surname><given-names>M</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Construction of <italic>Escherichia coli</italic> K-12 in-frame, single-gene knockout mutants: the Keio collection</article-title><source>Molecular Systems Biology</source><volume>2</volume><elocation-id>2006.0008</elocation-id><pub-id pub-id-type="doi">10.1038/msb4100050</pub-id><pub-id pub-id-type="pmid">16738554</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Babraham Bioinformatics</collab></person-group><year iso-8601-date="2024">2024</year><data-title>FastQC A quality control tool for high throughput sequence data</data-title><source>Bioinformatics</source><ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baeza</surname><given-names>N</given-names></name><name><surname>Mercade</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Relationship between membrane vesicles, extracellular ATP and biofilm formation in antarctic gram-negative bacteria</article-title><source>Microbial Ecology</source><volume>81</volume><fpage>645</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1007/s00248-020-01614-6</pub-id><pub-id pub-id-type="pmid">33025062</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bielaszewska</surname><given-names>M</given-names></name><name><surname>Rüter</surname><given-names>C</given-names></name><name><surname>Bauwens</surname><given-names>A</given-names></name><name><surname>Greune</surname><given-names>L</given-names></name><name><surname>Jarosch</surname><given-names>KA</given-names></name><name><surname>Steil</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Lloubes</surname><given-names>R</given-names></name><name><surname>Fruth</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Schmidt</surname><given-names>MA</given-names></name><name><surname>Dobrindt</surname><given-names>U</given-names></name><name><surname>Mellmann</surname><given-names>A</given-names></name><name><surname>Karch</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic <italic>Escherichia coli</italic> O157: Intracellular delivery, trafficking and mechanisms of cell injury</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006159</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006159</pub-id><pub-id pub-id-type="pmid">28158302</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittel</surname><given-names>M</given-names></name><name><surname>Reichert</surname><given-names>P</given-names></name><name><surname>Sarfati</surname><given-names>I</given-names></name><name><surname>Dressel</surname><given-names>A</given-names></name><name><surname>Leikam</surname><given-names>S</given-names></name><name><surname>Uderhardt</surname><given-names>S</given-names></name><name><surname>Stolzer</surname><given-names>I</given-names></name><name><surname>Phu</surname><given-names>TA</given-names></name><name><surname>Ng</surname><given-names>M</given-names></name><name><surname>Vu</surname><given-names>NK</given-names></name><name><surname>Tenzer</surname><given-names>S</given-names></name><name><surname>Distler</surname><given-names>U</given-names></name><name><surname>Wirtz</surname><given-names>S</given-names></name><name><surname>Rothhammer</surname><given-names>V</given-names></name><name><surname>Neurath</surname><given-names>MF</given-names></name><name><surname>Raffai</surname><given-names>RL</given-names></name><name><surname>Günther</surname><given-names>C</given-names></name><name><surname>Momma</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Visualizing transfer of microbial biomolecules by outer membrane vesicles in microbe-host-communication in vivo</article-title><source>Journal of Extracellular Vesicles</source><volume>10</volume><elocation-id>e12159</elocation-id><pub-id pub-id-type="doi">10.1002/jev2.12159</pub-id><pub-id pub-id-type="pmid">34664784</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitto</surname><given-names>NJ</given-names></name><name><surname>Chapman</surname><given-names>R</given-names></name><name><surname>Pidot</surname><given-names>S</given-names></name><name><surname>Costin</surname><given-names>A</given-names></name><name><surname>Lo</surname><given-names>C</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>D’Cruze</surname><given-names>T</given-names></name><name><surname>Reynolds</surname><given-names>EC</given-names></name><name><surname>Dashper</surname><given-names>SG</given-names></name><name><surname>Turnbull</surname><given-names>L</given-names></name><name><surname>Whitchurch</surname><given-names>CB</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Stacey</surname><given-names>KJ</given-names></name><name><surname>Ferrero</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Bacterial membrane vesicles transport their DNA cargo into host cells</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>7072</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-07288-4</pub-id><pub-id pub-id-type="pmid">28765539</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borisov</surname><given-names>VB</given-names></name><name><surname>Gennis</surname><given-names>RB</given-names></name><name><surname>Hemp</surname><given-names>J</given-names></name><name><surname>Verkhovsky</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The cytochrome bd respiratory oxygen reductases</article-title><source>Biochimica et Biophysica Acta</source><volume>1807</volume><fpage>1398</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2011.06.016</pub-id><pub-id pub-id-type="pmid">21756872</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Burnstock</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><chapter-title>Introduction to purinergic signaling</chapter-title><person-group person-group-type="editor"><name><surname>Pelegrín</surname><given-names>P</given-names></name></person-group><source>Purinergic Signaling</source><publisher-name>Springer</publisher-name><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9717-6_1</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Immune dysregulation in sepsis: experiences, lessons and perspectives</article-title><source>Cell Death Discovery</source><volume>9</volume><elocation-id>465</elocation-id><pub-id pub-id-type="doi">10.1038/s41420-023-01766-7</pub-id><pub-id pub-id-type="pmid">38114466</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title><source>Bioinformatics</source><volume>34</volume><fpage>i884</fpage><lpage>i890</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id><pub-id pub-id-type="pmid">30423086</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>U</given-names></name><name><surname>Lee</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct roles of outer membrane porins in antibiotic resistance and membrane integrity in <italic>Escherichia coli</italic></article-title><source>Frontiers in Microbiology</source><volume>10</volume><elocation-id>953</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.00953</pub-id><pub-id pub-id-type="pmid">31114568</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diekema</surname><given-names>DJ</given-names></name><name><surname>Hsueh</surname><given-names>PR</given-names></name><name><surname>Mendes</surname><given-names>RE</given-names></name><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Rolston</surname><given-names>KV</given-names></name><name><surname>Sader</surname><given-names>HS</given-names></name><name><surname>Jones</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>63</volume><elocation-id>e00355-19</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.00355-19</pub-id><pub-id pub-id-type="pmid">31010862</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Quah</surname><given-names>SY</given-names></name><name><surname>Tan</surname><given-names>KS</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Secreted adenosine triphosphate from Aggregatibacter actinomycetemcomitans triggers chemokine response</article-title><source>Molecular Oral Microbiology</source><volume>31</volume><fpage>423</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1111/omi.12143</pub-id><pub-id pub-id-type="pmid">26470857</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Tan</surname><given-names>KS</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>The danger signal extracellular ATP is an inducer of <italic>Fusobacterium nucleatum</italic> biofilm dispersal</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>6</volume><elocation-id>155</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2016.00155</pub-id><pub-id pub-id-type="pmid">27909688</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Virgilio</surname><given-names>F</given-names></name><name><surname>Sarti</surname><given-names>AC</given-names></name><name><surname>Coutinho-Silva</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Purinergic signaling, DAMPs, and inflammation</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>318</volume><fpage>C832</fpage><lpage>C835</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00053.2020</pub-id><pub-id pub-id-type="pmid">32159362</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dosch</surname><given-names>M</given-names></name><name><surname>Zindel</surname><given-names>J</given-names></name><name><surname>Jebbawi</surname><given-names>F</given-names></name><name><surname>Melin</surname><given-names>N</given-names></name><name><surname>Sanchez-Taltavull</surname><given-names>D</given-names></name><name><surname>Stroka</surname><given-names>D</given-names></name><name><surname>Candinas</surname><given-names>D</given-names></name><name><surname>Beldi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Connexin-43-dependent ATP release mediates macrophage activation during sepsis</article-title><source>eLife</source><volume>8</volume><elocation-id>e42670</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.42670</pub-id><pub-id pub-id-type="pmid">30735126</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichelberger</surname><given-names>KR</given-names></name><name><surname>Goldman</surname><given-names>WE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Manipulating neutrophil degranulation as a bacterial virulence strategy</article-title><source>PLOS Pathogens</source><volume>16</volume><elocation-id>e1009054</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009054</pub-id><pub-id pub-id-type="pmid">33301542</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eltzschig</surname><given-names>HK</given-names></name><name><surname>Sitkovsky</surname><given-names>MV</given-names></name><name><surname>Robson</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Purinergic signaling during inflammation</article-title><source>The New England Journal of Medicine</source><volume>367</volume><fpage>2322</fpage><lpage>2333</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1205750</pub-id><pub-id pub-id-type="pmid">23234515</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Exosome engineering: Current progress in cargo loading and targeted delivery</article-title><source>NanoImpact</source><volume>20</volume><elocation-id>100261</elocation-id><pub-id pub-id-type="doi">10.1016/j.impact.2020.100261</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galber</surname><given-names>C</given-names></name><name><surname>Carissimi</surname><given-names>S</given-names></name><name><surname>Baracca</surname><given-names>A</given-names></name><name><surname>Giorgio</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The ATP synthase deficiency in human diseases</article-title><source>Life</source><volume>11</volume><elocation-id>325</elocation-id><pub-id pub-id-type="doi">10.3390/life11040325</pub-id><pub-id pub-id-type="pmid">33917760</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gheinani</surname><given-names>AH</given-names></name><name><surname>Vögeli</surname><given-names>M</given-names></name><name><surname>Baumgartner</surname><given-names>U</given-names></name><name><surname>Vassella</surname><given-names>E</given-names></name><name><surname>Draeger</surname><given-names>A</given-names></name><name><surname>Burkhard</surname><given-names>FC</given-names></name><name><surname>Monastyrskaya</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>3945</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-22142-x</pub-id><pub-id pub-id-type="pmid">29500443</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosn</surname><given-names>EEB</given-names></name><name><surname>Cassado</surname><given-names>AA</given-names></name><name><surname>Govoni</surname><given-names>GR</given-names></name><name><surname>Fukuhara</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Monack</surname><given-names>DM</given-names></name><name><surname>Bortoluci</surname><given-names>KR</given-names></name><name><surname>Almeida</surname><given-names>SR</given-names></name><name><surname>Herzenberg</surname><given-names>LA</given-names></name><name><surname>Herzenberg</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Two physically, functionally, and developmentally distinct peritoneal macrophage subsets</article-title><source>PNAS</source><volume>107</volume><fpage>2568</fpage><lpage>2573</lpage><pub-id pub-id-type="doi">10.1073/pnas.0915000107</pub-id><pub-id pub-id-type="pmid">20133793</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grauel</surname><given-names>A</given-names></name><name><surname>Kägi</surname><given-names>J</given-names></name><name><surname>Rasmussen</surname><given-names>T</given-names></name><name><surname>Makarchuk</surname><given-names>I</given-names></name><name><surname>Oppermann</surname><given-names>S</given-names></name><name><surname>Moumbock</surname><given-names>AFA</given-names></name><name><surname>Wohlwend</surname><given-names>D</given-names></name><name><surname>Müller</surname><given-names>R</given-names></name><name><surname>Melin</surname><given-names>F</given-names></name><name><surname>Günther</surname><given-names>S</given-names></name><name><surname>Hellwig</surname><given-names>P</given-names></name><name><surname>Böttcher</surname><given-names>B</given-names></name><name><surname>Friedrich</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Structure of <italic>Escherichia coli</italic> cytochrome bd-II type oxidase with bound aurachin D</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>6498</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-26835-2</pub-id><pub-id pub-id-type="pmid">34764272</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hironaka</surname><given-names>I</given-names></name><name><surname>Iwase</surname><given-names>T</given-names></name><name><surname>Sugimoto</surname><given-names>S</given-names></name><name><surname>Okuda</surname><given-names>K</given-names></name><name><surname>Tajima</surname><given-names>A</given-names></name><name><surname>Yanaga</surname><given-names>K</given-names></name><name><surname>Mizunoe</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Glucose triggers ATP secretion from bacteria in a growth-phase-dependent manner</article-title><source>Applied and Environmental Microbiology</source><volume>79</volume><fpage>2328</fpage><lpage>2335</lpage><pub-id pub-id-type="doi">10.1128/AEM.03871-12</pub-id><pub-id pub-id-type="pmid">23354720</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihssen</surname><given-names>J</given-names></name><name><surname>Jovanovic</surname><given-names>N</given-names></name><name><surname>Sirec</surname><given-names>T</given-names></name><name><surname>Spitz</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Real-time monitoring of extracellular ATP in bacterial cultures using thermostable luciferase</article-title><source>PLOS ONE</source><volume>16</volume><elocation-id>e0244200</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0244200</pub-id><pub-id pub-id-type="pmid">33481792</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivancic</surname><given-names>V</given-names></name><name><surname>Mastali</surname><given-names>M</given-names></name><name><surname>Percy</surname><given-names>N</given-names></name><name><surname>Gornbein</surname><given-names>J</given-names></name><name><surname>Babbitt</surname><given-names>JT</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Landaw</surname><given-names>EM</given-names></name><name><surname>Bruckner</surname><given-names>DA</given-names></name><name><surname>Churchill</surname><given-names>BM</given-names></name><name><surname>Haake</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Rapid antimicrobial susceptibility determination of uropathogens in clinical urine specimens by use of ATP bioluminescence</article-title><source>Journal of Clinical Microbiology</source><volume>46</volume><fpage>1213</fpage><lpage>1219</lpage><pub-id pub-id-type="doi">10.1128/JCM.02036-07</pub-id><pub-id pub-id-type="pmid">18272708</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwase</surname><given-names>T</given-names></name><name><surname>Shinji</surname><given-names>H</given-names></name><name><surname>Tajima</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>F</given-names></name><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Iwamoto</surname><given-names>T</given-names></name><name><surname>Yoneda</surname><given-names>M</given-names></name><name><surname>Mizunoe</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Isolation and identification of ATP-secreting bacteria from mice and humans</article-title><source>Journal of Clinical Microbiology</source><volume>48</volume><fpage>1949</fpage><lpage>1951</lpage><pub-id pub-id-type="doi">10.1128/JCM.01941-09</pub-id><pub-id pub-id-type="pmid">20305009</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>SR</given-names></name><name><surname>Yoon</surname><given-names>YJ</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>OY</given-names></name><name><surname>Choi</surname><given-names>EJ</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><name><surname>Choi</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Di Vizio</surname><given-names>D</given-names></name><name><surname>Gho</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>In vivo kinetic biodistribution of nano-sized outer membrane vesicles derived from bacteria</article-title><source>Small</source><volume>11</volume><fpage>456</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1002/smll.201401803</pub-id><pub-id pub-id-type="pmid">25196673</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junger</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Immune cell regulation by autocrine purinergic signalling</article-title><source>Nature Reviews. Immunology</source><volume>11</volume><fpage>201</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1038/nri2938</pub-id><pub-id pub-id-type="pmid">21331080</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juodeikis</surname><given-names>R</given-names></name><name><surname>Carding</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Outer membrane vesicles: Biogenesis, functions, and issues</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>86</volume><elocation-id>e0003222</elocation-id><pub-id pub-id-type="doi">10.1128/mmbr.00032-22</pub-id><pub-id pub-id-type="pmid">36154136</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Kassambara</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Rstatix: pipe-friendly framework for basic statistical tests</data-title><version designator="0.7.2">0.7.2</version><source>R Packages</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/rstatix/index.html">https://cran.r-project.org/web/packages/rstatix/index.html</ext-link></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Yoon</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>EJ</given-names></name><name><surname>Yi</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Lötvall</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Gho</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Outer membrane vesicles derived from <italic>Escherichia coli</italic> up-regulate expression of endothelial cell adhesion molecules in vitro and in vivo</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e59276</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0059276</pub-id><pub-id pub-id-type="pmid">23516621</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="1959">1959</year><article-title>Death of bacteria in growing culture</article-title><source>Journal of Bacteriology</source><volume>77</volume><fpage>623</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1128/jb.77.5.623-629.1959</pub-id><pub-id pub-id-type="pmid">13654228</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Kolberg</surname><given-names>L</given-names></name><name><surname>Raudvere</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Gprofiler2: interface to the “g:profiler” toolset</data-title><version designator="0.2.2">0.2.2</version><source>R Packages</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/gprofiler2/index.html">https://cran.r-project.org/web/packages/gprofiler2/index.html</ext-link></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulp</surname><given-names>A</given-names></name><name><surname>Kuehn</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Biological functions and biogenesis of secreted bacterial outer membrane vesicles</article-title><source>Annual Review of Microbiology</source><volume>64</volume><fpage>163</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.091208.073413</pub-id><pub-id pub-id-type="pmid">20825345</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledderose</surname><given-names>C</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>Y</given-names></name><name><surname>Fakhari</surname><given-names>M</given-names></name><name><surname>Slubowski</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Junger</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Purinergic signaling and the immune response in sepsis: A review</article-title><source>Clinical Therapeutics</source><volume>38</volume><fpage>1054</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2016.04.002</pub-id><pub-id pub-id-type="pmid">27156007</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leduc</surname><given-names>M</given-names></name><name><surname>van Heijenoort</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Autolysis of <italic>Escherichia coli</italic></article-title><source>Journal of Bacteriology</source><volume>142</volume><fpage>52</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1128/jb.142.1.52-59.1980</pub-id><pub-id pub-id-type="pmid">6768717</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>EY</given-names></name><name><surname>Bang</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>GW</given-names></name><name><surname>Choi</surname><given-names>DS</given-names></name><name><surname>Kang</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Lee</surname><given-names>JO</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Kwon</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>KP</given-names></name><name><surname>Gho</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Global proteomic profiling of native outer membrane vesicles derived from <italic>Escherichia coli</italic></article-title><source>PROTEOMICS</source><volume>7</volume><fpage>3143</fpage><lpage>3153</lpage><pub-id pub-id-type="doi">10.1002/pmic.200700196</pub-id><pub-id pub-id-type="pmid">17787032</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Yoon</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Dinh</surname><given-names>NTH</given-names></name><name><surname>Go</surname><given-names>G</given-names></name><name><surname>Tae</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Park</surname><given-names>HT</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Roh</surname><given-names>TY</given-names></name><name><surname>Di Vizio</surname><given-names>D</given-names></name><name><surname>Gho</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Outer membrane vesicles derived from <italic>Escherichia coli</italic> regulate neutrophil migration by induction of endothelial IL-8</article-title><source>Frontiers in Microbiology</source><volume>9</volume><elocation-id>2268</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.02268</pub-id><pub-id pub-id-type="pmid">30369908</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leive</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1968">1968</year><article-title>Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate</article-title><source>The Journal of Biological Chemistry</source><volume>243</volume><fpage>2373</fpage><lpage>2380</lpage><pub-id pub-id-type="pmid">4967584</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennaárd</surname><given-names>AJ</given-names></name><name><surname>Mamand</surname><given-names>DR</given-names></name><name><surname>Wiklander</surname><given-names>RJ</given-names></name><name><surname>El Andaloussi</surname><given-names>S</given-names></name><name><surname>Wiklander</surname><given-names>OPB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Optimised electroporation for loading of extracellular vesicles with doxorubicin</article-title><source>Pharmaceutics</source><volume>14</volume><elocation-id>38</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics14010038</pub-id><pub-id pub-id-type="pmid">35056933</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lundin</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><chapter-title>Use of firefly luciferase in atp-related assays of biomass, enzymes, and metabolites</chapter-title><person-group person-group-type="editor"><name><surname>Lundin</surname><given-names>A</given-names></name></person-group><source>Methods in Enzymology</source><publisher-name>Elsevier</publisher-name><fpage>346</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(00)05499-9</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBroom</surname><given-names>AJ</given-names></name><name><surname>Johnson</surname><given-names>AP</given-names></name><name><surname>Vemulapalli</surname><given-names>S</given-names></name><name><surname>Kuehn</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Outer membrane vesicle production by <italic>Escherichia coli</italic> is independent of membrane instability</article-title><source>Journal of Bacteriology</source><volume>188</volume><fpage>5385</fpage><lpage>5392</lpage><pub-id pub-id-type="doi">10.1128/JB.00498-06</pub-id><pub-id pub-id-type="pmid">16855227</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mempin</surname><given-names>R</given-names></name><name><surname>Tran</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Kim Ho</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Release of extracellular ATP by bacteria during growth</article-title><source>BMC Microbiology</source><volume>13</volume><elocation-id>301</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-13-301</pub-id><pub-id pub-id-type="pmid">24364860</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>LV</given-names></name><name><surname>Gaborski</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Outer membrane vesicles as molecular biomarkers for Gram-negative sepsis: Taking advantage of nature’s perfect packages</article-title><source>The Journal of Biological Chemistry</source><volume>298</volume><elocation-id>102483</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2022.102483</pub-id><pub-id pub-id-type="pmid">36108741</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mureșan</surname><given-names>MG</given-names></name><name><surname>Balmoș</surname><given-names>IA</given-names></name><name><surname>Badea</surname><given-names>I</given-names></name><name><surname>Santini</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Abdominal sepsis: An update</article-title><source>The Journal of Critical Care Medicine</source><volume>4</volume><fpage>120</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.2478/jccm-2018-0023</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Oksanen</surname><given-names>J</given-names></name><name><surname>Simpson</surname><given-names>GL</given-names></name><name><surname>Blanchet</surname><given-names>FG</given-names></name><name><surname>Kindt</surname><given-names>R</given-names></name><name><surname>Legendre</surname><given-names>P</given-names></name><name><surname>Minchin</surname><given-names>PR</given-names></name><name><surname>O’Hara</surname><given-names>RB</given-names></name><name><surname>Solymos</surname><given-names>P</given-names></name><name><surname>Stevens</surname><given-names>MHH</given-names></name><name><surname>Szoecs</surname><given-names>E</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name><name><surname>Barbour</surname><given-names>M</given-names></name><name><surname>Bedward</surname><given-names>M</given-names></name><name><surname>Bolker</surname><given-names>B</given-names></name><name><surname>Borcard</surname><given-names>D</given-names></name><name><surname>Carvalho</surname><given-names>G</given-names></name><name><surname>Chirico</surname><given-names>M</given-names></name><name><surname>Caceres</surname><given-names>MD</given-names></name><name><surname>Durand</surname><given-names>S</given-names></name><name><surname>Weedon</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Vegan: community ecology package</data-title><version designator="2.6-4">2.6-4</version><source>R Packages</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/vegan/index.html">https://cran.r-project.org/web/packages/vegan/index.html</ext-link></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orench-Rivera</surname><given-names>N</given-names></name><name><surname>Kuehn</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Environmentally controlled bacterial vesicle-mediated export</article-title><source>Cellular Microbiology</source><volume>18</volume><fpage>1525</fpage><lpage>1536</lpage><pub-id pub-id-type="doi">10.1111/cmi.12676</pub-id><pub-id pub-id-type="pmid">27673272</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Choi</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Hong</surname><given-names>BS</given-names></name><name><surname>Kim</surname><given-names>OY</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Yoon</surname><given-names>CM</given-names></name><name><surname>Koh</surname><given-names>GY</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Gho</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Outer membrane vesicles derived from <italic>Escherichia coli</italic> induce systemic inflammatory response syndrome</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e11334</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0011334</pub-id><pub-id pub-id-type="pmid">20596524</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Jang</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>SR</given-names></name><name><surname>Jang</surname><given-names>MH</given-names></name><name><surname>Lötvall</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Gho</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pulmonary inflammation induced by bacteria-free outer membrane vesicles from <italic>Pseudomonas aeruginosa</italic></article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>49</volume><fpage>637</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2012-0370OC</pub-id><pub-id pub-id-type="pmid">23713467</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Cruz</surname><given-names>C</given-names></name><name><surname>Carrión</surname><given-names>O</given-names></name><name><surname>Delgado</surname><given-names>L</given-names></name><name><surname>Martinez</surname><given-names>G</given-names></name><name><surname>López-Iglesias</surname><given-names>C</given-names></name><name><surname>Mercade</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>New type of outer membrane vesicle produced by the Gram-negative bacterium Shewanella vesiculosa M7T: implications for DNA content</article-title><source>Applied and Environmental Microbiology</source><volume>79</volume><fpage>1874</fpage><lpage>1881</lpage><pub-id pub-id-type="doi">10.1128/AEM.03657-12</pub-id><pub-id pub-id-type="pmid">23315742</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Cruz</surname><given-names>C</given-names></name><name><surname>Delgado</surname><given-names>L</given-names></name><name><surname>López-Iglesias</surname><given-names>C</given-names></name><name><surname>Mercade</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Outer-inner membrane vesicles naturally secreted by gram-negative pathogenic bacteria</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0116896</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0116896</pub-id><pub-id pub-id-type="pmid">25581302</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perruzza</surname><given-names>L</given-names></name><name><surname>Gargari</surname><given-names>G</given-names></name><name><surname>Proietti</surname><given-names>M</given-names></name><name><surname>Fosso</surname><given-names>B</given-names></name><name><surname>D’Erchia</surname><given-names>AM</given-names></name><name><surname>Faliti</surname><given-names>CE</given-names></name><name><surname>Rezzonico-Jost</surname><given-names>T</given-names></name><name><surname>Scribano</surname><given-names>D</given-names></name><name><surname>Mauri</surname><given-names>L</given-names></name><name><surname>Colombo</surname><given-names>D</given-names></name><name><surname>Pellegrini</surname><given-names>G</given-names></name><name><surname>Moregola</surname><given-names>A</given-names></name><name><surname>Mooser</surname><given-names>C</given-names></name><name><surname>Pesole</surname><given-names>G</given-names></name><name><surname>Nicoletti</surname><given-names>M</given-names></name><name><surname>Norata</surname><given-names>GD</given-names></name><name><surname>Geuking</surname><given-names>MB</given-names></name><name><surname>McCoy</surname><given-names>KD</given-names></name><name><surname>Guglielmetti</surname><given-names>S</given-names></name><name><surname>Grassi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>T follicular helper cells promote a beneficial gut ecosystem for host metabolic homeostasis by sensing microbiota-derived extracellular ATP</article-title><source>Cell Reports</source><volume>18</volume><fpage>2566</fpage><lpage>2575</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.02.061</pub-id><pub-id pub-id-type="pmid">28297661</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proietti</surname><given-names>M</given-names></name><name><surname>Perruzza</surname><given-names>L</given-names></name><name><surname>Scribano</surname><given-names>D</given-names></name><name><surname>Pellegrini</surname><given-names>G</given-names></name><name><surname>D’Antuono</surname><given-names>R</given-names></name><name><surname>Strati</surname><given-names>F</given-names></name><name><surname>Raffaelli</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>SF</given-names></name><name><surname>Thelen</surname><given-names>M</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name><name><surname>Slack</surname><given-names>E</given-names></name><name><surname>Nicoletti</surname><given-names>M</given-names></name><name><surname>Grassi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>ATP released by intestinal bacteria limits the generation of protective IgA against enteropathogens</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>250</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-08156-z</pub-id><pub-id pub-id-type="pmid">30651557</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>OS</given-names></name><name><surname>Paramasivam</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>JCH</given-names></name><name><surname>Murrell-Lagnado</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis</article-title><source>Journal of Cell Science</source><volume>120</volume><fpage>3838</fpage><lpage>3849</lpage><pub-id pub-id-type="doi">10.1242/jcs.010348</pub-id><pub-id pub-id-type="pmid">17940064</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>A</given-names></name><name><surname>Dittel</surname><given-names>BN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Isolation of mouse peritoneal cavity cells</article-title><source>Journal of Visualized Experiments</source><volume>35</volume><elocation-id>1488</elocation-id><pub-id pub-id-type="doi">10.3791/1488</pub-id><pub-id pub-id-type="pmid">20110936</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimer</surname><given-names>SL</given-names></name><name><surname>Beniac</surname><given-names>DR</given-names></name><name><surname>Hiebert</surname><given-names>SL</given-names></name><name><surname>Booth</surname><given-names>TF</given-names></name><name><surname>Chong</surname><given-names>PM</given-names></name><name><surname>Westmacott</surname><given-names>GR</given-names></name><name><surname>Zhanel</surname><given-names>GG</given-names></name><name><surname>Bay</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Comparative analysis of outer membrane vesicle isolation methods with an <italic>Escherichia coli tolA</italic> mutant reveals a hypervesiculating phenotype with outer-inner membrane vesicle content</article-title><source>Frontiers in Microbiology</source><volume>12</volume><elocation-id>628801</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.628801</pub-id><pub-id pub-id-type="pmid">33746922</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhart</surname><given-names>K</given-names></name><name><surname>Daniels</surname><given-names>R</given-names></name><name><surname>Kissoon</surname><given-names>N</given-names></name><name><surname>Machado</surname><given-names>FR</given-names></name><name><surname>Schachter</surname><given-names>RD</given-names></name><name><surname>Finfer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Recognizing sepsis as a global health priority - A WHO resolution</article-title><source>The New England Journal of Medicine</source><volume>377</volume><fpage>414</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1056/NEJMp1707170</pub-id><pub-id pub-id-type="pmid">28658587</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rittirsch</surname><given-names>D</given-names></name><name><surname>Huber-Lang</surname><given-names>MS</given-names></name><name><surname>Flierl</surname><given-names>MA</given-names></name><name><surname>Ward</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Immunodesign of experimental sepsis by cecal ligation and puncture</article-title><source>Nature Protocols</source><volume>4</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.214</pub-id><pub-id pub-id-type="pmid">19131954</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>LE</given-names></name><name><surname>Murrell-Lagnado</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The trafficking and targeting of P2X receptors</article-title><source>Frontiers in Cellular Neuroscience</source><volume>7</volume><elocation-id>233</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2013.00233</pub-id><pub-id pub-id-type="pmid">24319412</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>N</given-names></name><name><surname>Rudis</surname><given-names>B</given-names></name><name><surname>Filipovic-Pierucci</surname><given-names>A</given-names></name><name><surname>Galili</surname><given-names>T</given-names></name><name><surname>Greenwell</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>sjmgarnier/viridis: viridis 0.6.0 (pre-CRAN release)</data-title><version designator="v0.6.0pre">v0.6.0pre</version><source>Zenodo</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.4679424">https://doi.org/10.5281/zenodo.4679424</ext-link></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudd</surname><given-names>KE</given-names></name><name><surname>Johnson</surname><given-names>SC</given-names></name><name><surname>Agesa</surname><given-names>KM</given-names></name><name><surname>Shackelford</surname><given-names>KA</given-names></name><name><surname>Tsoi</surname><given-names>D</given-names></name><name><surname>Kievlan</surname><given-names>DR</given-names></name><name><surname>Colombara</surname><given-names>DV</given-names></name><name><surname>Ikuta</surname><given-names>KS</given-names></name><name><surname>Kissoon</surname><given-names>N</given-names></name><name><surname>Finfer</surname><given-names>S</given-names></name><name><surname>Fleischmann-Struzek</surname><given-names>C</given-names></name><name><surname>Machado</surname><given-names>FR</given-names></name><name><surname>Reinhart</surname><given-names>KK</given-names></name><name><surname>Rowan</surname><given-names>K</given-names></name><name><surname>Seymour</surname><given-names>CW</given-names></name><name><surname>Watson</surname><given-names>RS</given-names></name><name><surname>West</surname><given-names>TE</given-names></name><name><surname>Marinho</surname><given-names>F</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name><name><surname>Lozano</surname><given-names>R</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>Murray</surname><given-names>CJL</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study</article-title><source>The Lancet</source><volume>395</volume><fpage>200</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(19)32989-7</pub-id><pub-id pub-id-type="pmid">31911147</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salm</surname><given-names>L</given-names></name><name><surname>Shim</surname><given-names>R</given-names></name><name><surname>Noskovicova</surname><given-names>N</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Gata6<sup>+</sup> large peritoneal macrophages: an evolutionarily conserved sentinel and effector system for infection and injury</article-title><source>Trends in Immunology</source><volume>44</volume><fpage>129</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.it.2022.12.002</pub-id><pub-id pub-id-type="pmid">36623953</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santapaola</surname><given-names>D</given-names></name><name><surname>Del Chierico</surname><given-names>F</given-names></name><name><surname>Petrucca</surname><given-names>A</given-names></name><name><surname>Uzzau</surname><given-names>S</given-names></name><name><surname>Casalino</surname><given-names>M</given-names></name><name><surname>Colonna</surname><given-names>B</given-names></name><name><surname>Sessa</surname><given-names>R</given-names></name><name><surname>Berlutti</surname><given-names>F</given-names></name><name><surname>Nicoletti</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Apyrase, the product of the virulence plasmid-encoded phoN2 (apy) gene of Shigella flexneri, is necessary for proper unipolar IcsA localization and for efficient intercellular spread</article-title><source>Journal of Bacteriology</source><volume>188</volume><fpage>1620</fpage><lpage>1627</lpage><pub-id pub-id-type="doi">10.1128/JB.188.4.1620-1627.2006</pub-id><pub-id pub-id-type="pmid">16452446</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwechheimer</surname><given-names>C</given-names></name><name><surname>Kuehn</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions</article-title><source>Nature Reviews. Microbiology</source><volume>13</volume><fpage>605</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3525</pub-id><pub-id pub-id-type="pmid">26373371</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scribano</surname><given-names>D</given-names></name><name><surname>Petrucca</surname><given-names>A</given-names></name><name><surname>Pompili</surname><given-names>M</given-names></name><name><surname>Ambrosi</surname><given-names>C</given-names></name><name><surname>Bruni</surname><given-names>E</given-names></name><name><surname>Zagaglia</surname><given-names>C</given-names></name><name><surname>Prosseda</surname><given-names>G</given-names></name><name><surname>Nencioni</surname><given-names>L</given-names></name><name><surname>Casalino</surname><given-names>M</given-names></name><name><surname>Polticelli</surname><given-names>F</given-names></name><name><surname>Nicoletti</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Polar localization of PhoN2, a periplasmic virulence-associated factor of Shigella flexneri, is required for proper IcsA exposition at the old bacterial pole</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e90230</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0090230</pub-id><pub-id pub-id-type="pmid">24587292</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Slowikowski</surname><given-names>K</given-names></name><name><surname>Schep</surname><given-names>A</given-names></name><name><surname>Hughes</surname><given-names>S</given-names></name><name><surname>Dang</surname><given-names>TK</given-names></name><name><surname>Lukauskas</surname><given-names>S</given-names></name><name><surname>Irisson</surname><given-names>JO</given-names></name><name><surname>Kamvar</surname><given-names>ZN</given-names></name><name><surname>Ryan</surname><given-names>T</given-names></name><name><surname>Christophe</surname><given-names>D</given-names></name><name><surname>Hiroaki</surname><given-names>Y</given-names></name><name><surname>Gramme</surname><given-names>P</given-names></name><name><surname>Abdol</surname><given-names>AM</given-names></name><name><surname>Barrett</surname><given-names>M</given-names></name><name><surname>Cannoodt</surname><given-names>R</given-names></name><name><surname>Krassowski</surname><given-names>M</given-names></name><name><surname>Chirico</surname><given-names>M</given-names></name><name><surname>Aphalo</surname><given-names>P</given-names></name><name><surname>Barton</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Ggrepel: automatically position non-overlapping text labels with “ggplot2.”</data-title><version designator="0.9.5">0.9.5</version><source>R Packages</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggrepel/index.html">https://cran.r-project.org/web/packages/ggrepel/index.html</ext-link></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spari</surname><given-names>D</given-names></name><name><surname>Beldi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Extracellular ATP as an inter-kingdom signaling molecule: Release Mechanisms by bacteria and its implication on the host</article-title><source>International Journal of Molecular Sciences</source><volume>21</volume><elocation-id>5590</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21155590</pub-id><pub-id pub-id-type="pmid">32759857</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaki</surname><given-names>K</given-names></name><name><surname>Tahara</surname><given-names>YO</given-names></name><name><surname>Nakamichi</surname><given-names>N</given-names></name><name><surname>Hasegawa</surname><given-names>Y</given-names></name><name><surname>Shintani</surname><given-names>M</given-names></name><name><surname>Ohkuma</surname><given-names>M</given-names></name><name><surname>Miyata</surname><given-names>M</given-names></name><name><surname>Futamata</surname><given-names>H</given-names></name><name><surname>Tashiro</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multilamellar and multivesicular outer membrane vesicles produced by a buttiauxella agrestis <italic>tolB</italic> Mutant</article-title><source>Applied and Environmental Microbiology</source><volume>86</volume><elocation-id>e01131-20</elocation-id><pub-id pub-id-type="doi">10.1128/AEM.01131-20</pub-id><pub-id pub-id-type="pmid">32801184</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyofuku</surname><given-names>M</given-names></name><name><surname>Nomura</surname><given-names>N</given-names></name><name><surname>Eberl</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Types and origins of bacterial membrane vesicles</article-title><source>Nature Reviews. Microbiology</source><volume>17</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0112-2</pub-id><pub-id pub-id-type="pmid">30397270</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsubaki</surname><given-names>M</given-names></name><name><surname>Hori</surname><given-names>H</given-names></name><name><surname>Mogi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Probing molecular structure of dioxygen reduction site of bacterial quinol oxidases through ligand binding to the redox metal centers</article-title><source>Journal of Inorganic Biochemistry</source><volume>82</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/s0162-0134(00)00140-9</pub-id><pub-id pub-id-type="pmid">11132627</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbull</surname><given-names>L</given-names></name><name><surname>Toyofuku</surname><given-names>M</given-names></name><name><surname>Hynen</surname><given-names>AL</given-names></name><name><surname>Kurosawa</surname><given-names>M</given-names></name><name><surname>Pessi</surname><given-names>G</given-names></name><name><surname>Petty</surname><given-names>NK</given-names></name><name><surname>Osvath</surname><given-names>SR</given-names></name><name><surname>Cárcamo-Oyarce</surname><given-names>G</given-names></name><name><surname>Gloag</surname><given-names>ES</given-names></name><name><surname>Shimoni</surname><given-names>R</given-names></name><name><surname>Omasits</surname><given-names>U</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><name><surname>Yap</surname><given-names>X</given-names></name><name><surname>Monahan</surname><given-names>LG</given-names></name><name><surname>Cavaliere</surname><given-names>R</given-names></name><name><surname>Ahrens</surname><given-names>CH</given-names></name><name><surname>Charles</surname><given-names>IG</given-names></name><name><surname>Nomura</surname><given-names>N</given-names></name><name><surname>Eberl</surname><given-names>L</given-names></name><name><surname>Whitchurch</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Explosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilms</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11220</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11220</pub-id><pub-id pub-id-type="pmid">27075392</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Praszkier</surname><given-names>J</given-names></name><name><surname>Hutton</surname><given-names>ML</given-names></name><name><surname>Steer</surname><given-names>D</given-names></name><name><surname>Ramm</surname><given-names>G</given-names></name><name><surname>Kaparakis-Liaskos</surname><given-names>M</given-names></name><name><surname>Ferrero</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Increased outer membrane vesicle formation in a <italic>Helicobacter pylori</italic> tolB mutant</article-title><source>Helicobacter</source><volume>20</volume><fpage>269</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1111/hel.12196</pub-id><pub-id pub-id-type="pmid">25669590</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Gassen</surname><given-names>S</given-names></name><name><surname>Callebaut</surname><given-names>B</given-names></name><name><surname>Van Helden</surname><given-names>MJ</given-names></name><name><surname>Lambrecht</surname><given-names>BN</given-names></name><name><surname>Demeester</surname><given-names>P</given-names></name><name><surname>Dhaene</surname><given-names>T</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data</article-title><source>Cytometry. Part A</source><volume>87</volume><fpage>636</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1002/cyto.a.22625</pub-id><pub-id pub-id-type="pmid">25573116</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vega-Pérez</surname><given-names>A</given-names></name><name><surname>Villarrubia</surname><given-names>LH</given-names></name><name><surname>Godio</surname><given-names>C</given-names></name><name><surname>Gutiérrez-González</surname><given-names>A</given-names></name><name><surname>Feo-Lucas</surname><given-names>L</given-names></name><name><surname>Ferriz</surname><given-names>M</given-names></name><name><surname>Martínez-Puente</surname><given-names>N</given-names></name><name><surname>Alcaín</surname><given-names>J</given-names></name><name><surname>Mora</surname><given-names>A</given-names></name><name><surname>Sabio</surname><given-names>G</given-names></name><name><surname>López-Bravo</surname><given-names>M</given-names></name><name><surname>Ardavín</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Resident macrophage-dependent immune cell scaffolds drive anti-bacterial defense in the peritoneal cavity</article-title><source>Immunity</source><volume>54</volume><fpage>2578</fpage><lpage>2594</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2021.10.007</pub-id><pub-id pub-id-type="pmid">34717795</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Warnes</surname><given-names>GR</given-names></name><name><surname>Bolker</surname><given-names>B</given-names></name><name><surname>Bonebakker</surname><given-names>L</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Liaw</surname><given-names>A</given-names></name><name><surname>Lumley</surname><given-names>T</given-names></name><name><surname>Maechler</surname><given-names>M</given-names></name><name><surname>Magnusson</surname><given-names>A</given-names></name><name><surname>Moeller</surname><given-names>S</given-names></name><name><surname>Schwartz</surname><given-names>M</given-names></name><name><surname>Venables</surname><given-names>B</given-names></name><name><surname>Galili</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Gplots: various R programming tools for plotting data</data-title><version designator="3.1.3">3.1.3</version><source>R Packages</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/gplots/index.html">https://cran.r-project.org/web/packages/gplots/index.html</ext-link></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisburg</surname><given-names>WG</given-names></name><name><surname>Barns</surname><given-names>SM</given-names></name><name><surname>Pelletier</surname><given-names>DA</given-names></name><name><surname>Lane</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>16S ribosomal DNA amplification for phylogenetic study</article-title><source>Journal of Bacteriology</source><volume>173</volume><fpage>697</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1128/jb.173.2.697-703.1991</pub-id><pub-id pub-id-type="pmid">1987160</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><source>Ggplot2</source><publisher-name>Springer International Publishing</publisher-name><pub-id pub-id-type="doi">10.1007/978-3-319-24277-4</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name><name><surname>Bryan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023a</year><data-title>readxl: Read Excel Files</data-title><version designator="1.4.3">1.4.3</version><source>R Packages</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/readxl/index.html">https://cran.r-project.org/web/packages/readxl/index.html</ext-link></element-citation></ref><ref id="bib87"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name><name><surname>François</surname><given-names>R</given-names></name><name><surname>Henry</surname><given-names>L</given-names></name><name><surname>Müller</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2023">2023b</year><data-title>Dplyr: A grammar of data manipulation</data-title><version designator="1.1.4">1.1.4</version><source>R Packages</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/dplyr/index.html">https://cran.r-project.org/web/packages/dplyr/index.html</ext-link></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Use <italic>ggbreak</italic> to effectively utilize plotting space to deal with large datasets and outliers</article-title><source>Frontiers in Genetics</source><volume>12</volume><elocation-id>774846</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2021.774846</pub-id><pub-id pub-id-type="pmid">34795698</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>N</given-names></name><name><surname>Nakahigashi</surname><given-names>K</given-names></name><name><surname>Nakamichi</surname><given-names>T</given-names></name><name><surname>Yoshino</surname><given-names>M</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Touda</surname><given-names>Y</given-names></name><name><surname>Furubayashi</surname><given-names>A</given-names></name><name><surname>Kinjyo</surname><given-names>S</given-names></name><name><surname>Dose</surname><given-names>H</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Nakayashiki</surname><given-names>T</given-names></name><name><surname>Tomita</surname><given-names>M</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Update on the Keio collection of <italic>Escherichia coli</italic> single-gene deletion mutants</article-title><source>Molecular Systems Biology</source><volume>5</volume><elocation-id>335</elocation-id><pub-id pub-id-type="doi">10.1038/msb.2009.92</pub-id><pub-id pub-id-type="pmid">20029369</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yegutkin</surname><given-names>GG</given-names></name><name><surname>Mikhailov</surname><given-names>A</given-names></name><name><surname>Samburski</surname><given-names>SS</given-names></name><name><surname>Jalkanen</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The detection of micromolar pericellular ATP pool on lymphocyte surface by using lymphoid ecto-adenylate kinase as intrinsic ATP sensor</article-title><source>Molecular Biology of the Cell</source><volume>17</volume><fpage>3378</fpage><lpage>3385</lpage><pub-id pub-id-type="doi">10.1091/mbc.e05-10-0993</pub-id><pub-id pub-id-type="pmid">16707571</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Pache</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Khodabakhshi</surname><given-names>AH</given-names></name><name><surname>Tanaseichuk</surname><given-names>O</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Chanda</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1523</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id><pub-id pub-id-type="pmid">30944313</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zindel</surname><given-names>J</given-names></name><name><surname>Peiseler</surname><given-names>M</given-names></name><name><surname>Hossain</surname><given-names>M</given-names></name><name><surname>Deppermann</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>WY</given-names></name><name><surname>Haenni</surname><given-names>B</given-names></name><name><surname>Zuber</surname><given-names>B</given-names></name><name><surname>Deniset</surname><given-names>JF</given-names></name><name><surname>Surewaard</surname><given-names>BGJ</given-names></name><name><surname>Candinas</surname><given-names>D</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Primordial GATA6 macrophages function as extravascular platelets in sterile injury</article-title><source>Science</source><volume>371</volume><elocation-id>eabe0595</elocation-id><pub-id pub-id-type="doi">10.1126/science.abe0595</pub-id><pub-id pub-id-type="pmid">33674464</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus, female</italic>)</td><td align="left" valign="bottom">Wild-type mice</td><td align="left" valign="bottom">Inotiv, the Netherlands</td><td align="left" valign="bottom">C57Bl/6JRccHsd</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Enterococcus faecalis</italic>)</td><td align="left" valign="bottom">Iso1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>NA</italic></td><td align="left" valign="bottom">See Materials and methods: Human data</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">Iso2</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>NA</italic></td><td align="left" valign="bottom">See Materials and methods: Human data</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Klebsiella pneumoniae</italic>)</td><td align="left" valign="bottom">Iso3</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>NA</italic></td><td align="left" valign="bottom">See Materials and methods: Human data</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Staphylococcus aureus</italic>)</td><td align="left" valign="bottom">Iso4</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>NA</italic></td><td align="left" valign="bottom">See Materials and methods: Human data</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. faecalis</italic>)</td><td align="left" valign="bottom">Iso5</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>NA</italic></td><td align="left" valign="bottom">See Materials and methods: CLP sepsis model</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom">Iso6</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>NA</italic></td><td align="left" valign="bottom">See Materials and methods: CLP sepsis model</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>S. aureus</italic>)</td><td align="left" valign="bottom">Iso7</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>NA</italic></td><td align="left" valign="bottom">See Materials and methods: CLP sepsis model</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom">Parental strain (PS)</td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">BW25113</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔcyoA</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW0422-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔcyoB</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW0421-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔcyoC</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW0420-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔcyoD</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW0419-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔatpA</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3712-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔatpB</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3716-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔatpC</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3709-2</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔatpD</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3710-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔatpE</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3715-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔatpF</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3714-2</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔatpH</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3713-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔompF</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW0912-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig3">Figure 3</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔompC</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW2203-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig3">Figure 3</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔlamB</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3996-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig3">Figure 3</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔphoE</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW0231-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig3">Figure 3</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔmlaA</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW2343-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig5">Figure 5</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔmlaE</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3161-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig5">Figure 5</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔnlpI</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3132-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig5">Figure 5</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔtolB</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW5100-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig5">Figure 5</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔdegP</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW0157-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig5">Figure 5</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔrfaD</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW3594-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig5">Figure 5</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom"><italic>ΔrodZ</italic></td><td align="left" valign="bottom">Keio collection; <xref ref-type="bibr" rid="bib5">Baba et al., 2006</xref></td><td align="left" valign="bottom">JW2500-1</td><td align="left" valign="bottom">See <xref ref-type="fig" rid="fig5">Figure 5</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Purified anti-Ms CD16/32, monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 101302; clone 93; Lot# B298973; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312801">AB_312801</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms Ly-6G (FITC), monoclonal</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 551460; clone 1A8; Lot# 9068981; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_394207">AB_394207</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms Ly-6C (PerCP-Cyanine5.5), monoclonal</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 45-5932-82; clone HK1.4; Lot# 2309273; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2723343">AB_2723343</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms/Hs CD11b (APC), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 101212; clone M1/70; Lot# B312600; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312795">AB_312795</ext-link></td><td align="char" char="." valign="bottom">(1:800)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms CD206 (AF700), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 141733; clone C068C2; Lot# B278058; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2629636">AB_2629636</ext-link></td><td align="char" char="." valign="bottom">(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Armenian hamster anti-Ms CD11c (APC-eFluor780), monoclonal</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 47-0114-80; clone N418; Lot# 2133269; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1548652">AB_1548652</ext-link></td><td align="char" char="." valign="bottom">(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms CD45 (efluor450), monoclonal</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 48-0451-82; clone 30-F11; Lot# 2005853 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1518806">AB_1518806</ext-link></td><td align="char" char="." valign="bottom">(1:600)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms CD19 (Super Bright 600), monoclonal</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 63-0193-82; clone eBio1D3; Lot# 2366423; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2637308">AB_2637308</ext-link></td><td align="char" char="." valign="bottom">(1:150)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms CD3 (BV 605), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 100237; clone 17A2; Lot# B389899; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2562039">AB_2562039</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse anti-Ms NK1.1 (BV605), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 108739; clone PK-136; Lot# B389899; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2562273">AB_2562273</ext-link></td><td align="char" char="." valign="bottom">(1:150)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms CCR2 (BV650), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 150613; clone SA203G11; Lot# B294599; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2721553">AB_2721553</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms I-A/I-E (BV711), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 107643; clone M5/114.15.2; Lot# B299330; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2565976">AB_2565976</ext-link></td><td align="char" char="." valign="bottom">(1:600)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse anti-Ms CX3CR1 (BV785), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 149029; clone SA011F11; Lot# B304744; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2565938">AB_2565938</ext-link></td><td align="char" char="." valign="bottom">(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms Siglec F (PE), monoclonal</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 12-1702-80; clone 1RNM44N; Lot# 2252684; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2637129">AB_2637129</ext-link></td><td align="char" char="." valign="bottom">(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Armenian hamster anti-Ms FcεR1α (PE/Dazzle 594), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 134331; clone MAR-1; Lot# B280348; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687240">AB_2687240</ext-link></td><td align="char" char="." valign="bottom">(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms CD115 (PE-Cy7), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 135523; clone AFS98; Lot# B268547; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2566459">AB_2566459</ext-link></td><td align="char" char="." valign="bottom">(1:600)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms F4/80 (BUV395), monoclonal</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 565614; clone T45-2342; Lot# 1104580; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2739304">AB_2739304</ext-link></td><td align="char" char="." valign="bottom">(1:150)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms CD45 (APC-Cy7), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 103115; clone 30-F11; Lot# <italic>NA</italic>; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312980">AB_312980</ext-link></td><td align="char" char="." valign="bottom">(1:150)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms Ly-6C (PE-Cy7), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 128017; clone HK1.4; Lot# B331355; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1732093">AB_1732093</ext-link></td><td align="char" char="." valign="bottom">(1:600)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-Ms Ly-6G (Biotin), monoclonal</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 127604; clone 1A8; Lot# B314606; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1186108">AB_1186108</ext-link></td><td align="char" char="." valign="bottom">(1:600)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-<italic>E. coli</italic> ftsZ, polyclonal</td><td align="left" valign="bottom">Agrisera</td><td align="left" valign="bottom">Cat# AS10715; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10754647">AB_10754647</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-<italic>E. coli</italic> ompF, polyclonal</td><td align="left" valign="bottom">Biorbyt</td><td align="left" valign="bottom">Cat# orb308741; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:NA">NA</ext-link></td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit, polyclonal</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 925-68021; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2713919">AB_2713919</ext-link></td><td align="left" valign="bottom">(1:10,000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pBAD28==pEMPTY<break/>(plasmid)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib61">Proietti et al., 2019</xref>; <xref ref-type="bibr" rid="bib71">Santapaola et al., 2006</xref>; <xref ref-type="bibr" rid="bib73">Scribano et al., 2014</xref></td><td align="left" valign="bottom">Ampicillin resistance</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pHND10==pAPY<break/>(plasmid)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib61">Proietti et al., 2019</xref>; <xref ref-type="bibr" rid="bib71">Santapaola et al., 2006</xref>; <xref ref-type="bibr" rid="bib73">Scribano et al., 2014</xref></td><td align="left" valign="bottom">Ampicillin resistance</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">fD1</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib84">Weisburg et al., 1991</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-AGA-GTT-TGA-TCC-TGG-CTC-AG-3’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">fD2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib84">Weisburg et al., 1991</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-AGA-GTT-TGA-TCA-TGG-CTC-AG-3’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">rP1</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib84">Weisburg et al., 1991</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-ACG-GTT-ACC-TTG-TTA-CGA-CTT-3’</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QIAquick Gel Extraction Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 28706</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ATP Kit SL</td><td align="left" valign="bottom">BioThema</td><td align="left" valign="bottom">Cat# 144-041</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Cell Viability Kit with BD Liquid Counting Beads</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 349480</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Microbial ATP Kit HS</td><td align="left" valign="bottom">BioThema</td><td align="left" valign="bottom">Cat# 266-112</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Intracellular ATP Kit HS</td><td align="left" valign="bottom">BioThema</td><td align="left" valign="bottom">Cat# 266-111</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ReliaPrep RNA Cell Miniprep System</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# Z6011</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bacto Yeast Extract</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat# 212750</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bacto Tryptone</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat# 211699</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Agar</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# 05039-500G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">GoTaq G2 Green Master Mix</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# M782A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagenase I (Col I)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# C0130-100MG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagenase IV (Col IV)</td><td align="left" valign="bottom">Worthington</td><td align="left" valign="bottom">Cat# LS004189</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagenase D (Col D)</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat# 11088858001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DNAse I</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat# 63792800</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Adenosine 5′-triphosphate disodium salt hydrate (ATP)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# 2383-1G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Adenosine-5'-(γ-thio)-triphosphate, Tetralithium salt (ATPγs)</td><td align="left" valign="bottom">Jena Bioscience</td><td align="left" valign="bottom">Cat# NU-406-50</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism v9.5.1</td><td align="left" valign="bottom">Prism GraphPad software</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo v10.8.1</td><td align="left" valign="bottom">FlowJo software</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com">https://www.flowjo.com</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">fastqc v0.11.9</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib6">Babraham Bioinformatics, 2024</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">fastp v0.19.5</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Chen et al., 2018</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/OpenGene/fastp">https://github.com/OpenGene/fastp</ext-link><break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016962">SCR_016962</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR v2.7.10a_alpha_220818</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib20">Dobin et al., 2013</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/alexdobin/STAR">https://github.com/alexdobin/STAR</ext-link><break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_004463">SCR_004463</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">subread v2.0.1</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib47">Liao et al., 2014</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/ShiLab-Bioinformatics/subread">https://github.com/ShiLab-Bioinformatics/subread</ext-link><break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_009803">SCR_009803</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R v4.2.2</td><td align="left" valign="bottom">The R Project for Statistical Computing</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org">https://cran.r-project.org</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RStudio v2022.07.2</td><td align="left" valign="bottom">RStudio Desktop</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.rstudio.com">https://www.rstudio.com</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package ggplot2 v3.4.3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib85">Wickham, 2016</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://ggplot2.tidyverse.org">https://ggplot2.tidyverse.org</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package readxl v1.4.3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib86">Wickham and Bryan, 2023a</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=readxl">https://CRAN.R-project.org/package=readxl</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package ggbreak v0.1.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib88">Xu et al., 2021</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/YuLab-SMU/ggbreak">https://github.com/YuLab-SMU/ggbreak</ext-link><break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014601">SCR_014601</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package rstatix v0.7.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Kassambara, 2023</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=rstatix">https://CRAN.R-project.org/package=rstatix</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package dplyr v1.0.10</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib87">Wickham et al., 2023b</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=dplyr">https://CRAN.R-project.org/package=dplyr</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package DESeq2 v1.38.3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Love et al., 2014</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/mikelove/DESeq2">https://github.com/mikelove/DESeq2</ext-link><break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015687">SCR_015687</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package ggrepel v0.9.3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib74">Slowikowski et al., 2023</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=ggrepel">https://CRAN.R-project.org/package=ggrepel</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package vegan v2.6–4</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib54">Oksanen et al., 2022</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/vegandevs/vegan">https://github.com/vegandevs/vegan</ext-link><break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011950">SCR_011950</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package pairwiseAdonis v0.4</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Arbizu, 2023</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/pmartinezarbizu/pairwiseAdonis">https://github.com/pmartinezarbizu/pairwiseAdonis</ext-link><break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001905">SCR_001905</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package gprofiler2 v0.2.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Kolberg and Raudvere, 2023</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/gprofiler2/index.html">https://cran.r-project.org/web/packages/gprofiler2/index.html</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package gplots v3.1.3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib83">Warnes et al., 2022</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=gplots">https://CRAN.R-project.org/package=gplots</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package viridis v0.6.3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib68">Ross et al., 2021</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://sjmgarnier.github.io/viridis/">https://sjmgarnier.github.io/viridis/</ext-link><break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016696">SCR_016696</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Fixable Viability Dye eFluor506</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 65-0866-18</td><td align="char" char="." valign="bottom">(1:600)</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Nalgene Rapid-Flow PES Filter Units</td><td align="left" valign="bottom">Thermo Scientific</td><td align="left" valign="bottom">Cat# 168-0045, 165-0045, 124-0045PK</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Vybrant DiI Cell-Labeling Solution</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# V22885</td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DAPI</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# D9542-5MG</td><td align="left" valign="bottom">(1:5000)</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Hoechst 33342</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# H3570</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">LysoTracker</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# L12492</td><td align="char" char="." valign="bottom">(1:1000)</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96678.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Takeda</surname><given-names>Kiyoshi</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Osaka University</institution><country>Japan</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Fundamental</kwd></kwd-group></front-stub><body><p>This <bold>fundamental</bold> study advances our understanding of the role of bacterial-derived extracellular ATP in the pathogenesis of sepsis. The evidence supporting the conclusions is <bold>compelling</bold>, although not all concerns from a previous round of reviews were adequately addressed. The work will be of broad interest to researchers on microbiology and infectious diseases.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96678.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Extracellular ATP represents a danger-associated molecular pattern associated to tissue damage and can act also in an autocrine fashion in macrophages to promote proinflammatory responses, as observed in a previous paper by the authors in abdominal sepsis. The present study addresses an important aspect possibly conditioning the outcome of sepsis that is the release of ATP by bacteria. The authors show that sepsis-associated bacteria do in fact release ATP in a growth dependent and strain-specific manner. However, whether this bacterial derived ATP play a role in the pathogenesis of abdominal sepsis has not been determined. To address this question, a number of mutant strains of <italic>E. coli</italic> has been used first to correlate bacterial ATP release with growth and then, with outer membrane integrity and bacterial death. By using E. coli transformants expressing the ATP-degrading enzyme apyrase in the periplasmic space, the paper nicely shows that abdominal sepsis by these transformants results in significantly improved survival. This effect was associated to the reduction of small peritoneal macrophages and CX3CR1+ monocytes, and increase in neutrophils. To extrapolate the function of bacterial ATP from the systemic response to microorganisms, the authors exploited bacterial OMVs either loaded or not with ATP to investigate the systemic effects devoid of living microorganisms. This approach showed that ATP-loaded OMVs induced degranulation of neutrophils after lysosomal uptake, suggesting this mechanism could contribute to sepsis severity.</p><p>Strengths:</p><p>The most compelling part of the study is the analysis of <italic>E. coli</italic> mutants to address different aspects of bacterial release of ATP that could be pathogenically relevant during systemic dissemination of bacteria in the host.</p><p>Weaknesses:</p><p>As pointed out in the limitations of the study whether ATP-loaded OMVs could provide a mechanistic proof of the pathogenetic role of bacteria-derived ATP independently of live microorganisms in sepsis is interesting but not definitively convincing. It could be useful to see whether degranulation of neutrophils is differently induced also by apyrase-expressing vs control <italic>E. coli</italic> transformants. Also, the increase of neutrophils in bacterial ATP-depleted abdominal sepsis, which has better outcome than &quot;ATP-proficient&quot; sepsis, seems difficult to correlate to the hypothesized tissue damage induced by ATP delivered via non-infectious OMVs. Is neutrophils count affected by ATP delivered via OMVs? Probably a comparison of cytokine profiles in the abdominal fluids of <italic>E. coli</italic> and OMV treated animals could be helpful in defining the different responses induced by OMV-delivered vs bacterial-released ATP.</p><p>The analyses performed on OMV treated versus <italic>E. coli</italic> infected mice are not immediately related and difficult to combine when trying to draw a pathogenetic hypothesis for bacterial ATP in sepsis.</p><p>It's not clear why lung neutrophils were used for RNAseq.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96678.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In their manuscript, Daniel Spari et al. explored the dual role of ATP in exacerbating sepsis, revealing that ATP from both host and bacteria significantly impacts immune responses and disease progression.</p><p>Strengths:</p><p>The study meticulously examines the complex relationship between ATP release and bacterial growth, membrane integrity, and how bacterial ATP potentially dampens inflammatory responses, thereby impairing survival in sepsis models. Additionally, this compelling paper implies a concept that bacterial OMVs act as vehicles for the systemic distribution of ATP, influencing neutrophil activity and exacerbating sepsis severity.</p><p>Weaknesses:</p><p>(1) The researchers extracted and cultivated abdominal fluid on LB agar plates, then randomly picked 25 colonies for analysis. However, they didn't conduct 16S sequencing on the fluid itself. It's worth noting that the bacterial species present may vary depending on the individual patients. It would be beneficial if the authors could specify whether they've verified the existence of unculturable species capable of secreting high levels of Extracellular ATP.</p><p>(2) Do mice lacking commensal bacteria show a lack of Extracellular ATP following cecal ligation puncture?</p><p>(3) The authors isolated various bacteria from abdominal fluid, encompassing both Gram-negative and Gram-positive types. Nevertheless, their emphasis appeared to be primarily on the Gram-negative <italic>E. coli</italic>. It would be beneficial to ascertain whether the mechanisms of Extracellular ATP release differ between Gram-positive and Gram-negative bacteria. This is particularly relevant given that the Gram-positive bacterium E. faecalis, also isolated from the abdominal fluid, is recognized for its propensity to release substantial amounts of Extracellular ATP.</p><p>(4) The authors observed changes in the levels of LPM, SPM, and neutrophils in vivo. However, it remains uncertain whether the proliferation or migration of these cells is modulated or inhibited by ATP receptors like P2Y receptors. This aspect requires further investigation to establish a convincing connection.</p><p>(5) Additionally, is it possible that the observed in vivo changes could be triggered by bacterial components other than Extracellular ATP? In this research field, a comprehensive collection of inhibitors is available, so it is desirable to utilize them to demonstrate clearer results.</p><p>(6) Have the authors considered the role of host-derived Extracellular ATP in the context of inflammation?</p><p>(7) The authors mention that Extracellular ATP is rapidly hydrolyzed by ectonucleotases in vivo. Are the changes of immune cells within the peritoneal cavity caused by Extracellular ATP released from bacterial death or by OMVs?</p><p>(8) In the manuscript, the sample size (n) for the data consistently remains at 2. I would suggest expanding the sample size to enhance the robustness and rigor of the results.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96678.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Spari</surname><given-names>Daniel</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital of Bern</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Schmid</surname><given-names>Annina</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital of Bern</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Sanchez-Taltavull</surname><given-names>Daniel</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital of Bern</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Murugan</surname><given-names>Shaira</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital of Bern</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Keller</surname><given-names>Keely</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital of Bern</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Ennaciri</surname><given-names>Nadia</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital of Bern</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Salm</surname><given-names>Lilian</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital of Bern</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Stroka</surname><given-names>Deborah</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital of Bern</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Beldi</surname><given-names>Guido</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital of Bern</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><p>The points raised let us critically rethink our approach, our results, and our conclusions. Furthermore, it gave us the chance to elaborate on some critical aspects that were mentioned. With the help of the reviewers, we made some clarifications in the point-by-point responses and implemented them in the manuscript. Furthermore, we modified the figures as suggested:</p><p>- The colors in Figure 1C, D, G and H have been adapted as suggested</p><p>- We added a Figure2-figure supplement 1, which strengthens our conclusion in Figure 2</p><p>- As asked by reviewer #1 (weaknesses #3), we added the data about neutrophil numbers in the different organs (Figure 6-figure supplement 3C).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>- Extracellular ATP represents a danger-associated molecular pattern associated to tissue damage and can act also in an autocrine fashion in macrophages to promote proinflammatory responses, as observed in a previous paper by the authors in abdominal sepsis. The present study addresses an important aspect possibly conditioning the outcome of sepsis that is the release of ATP by bacteria. The authors show that sepsis-associated bacteria do in fact release ATP in a growth dependent and strain-specific manner. However, whether this bacterial derived ATP play a role in the pathogenesis of abdominal sepsis has not been determined. To address this question, a number of mutant strains of <italic>E. coli</italic> has been used first to correlate bacterial ATP release with growth and then, with outer membrane integrity and bacterial death. By using <italic>E. coli</italic> transformants expressing the ATP-degrading enzyme apyrase in the periplasmic space, the paper nicely shows that abdominal sepsis by these transformants results in significantly improved survival. This effect was associated with a reduction of peritoneal macrophages and CX3CR1+ monocytes, and an increase in neutrophils. To extrapolate the function of bacterial ATP from the systemic response to microorganisms, the authors exploited bacterial OMVs either loaded or not with ATP to investigate the systemic effects devoid of living microorganisms. This approach showed that ATP-loaded OMVs induced degranulation of neutrophils after lysosomal uptake, suggesting that this mechanism could contribute to sepsis severity.</p><p>Strengths:</p><p>- A strong part of the study is the analysis of <italic>E. coli</italic> mutants to address different aspects of bacterial release of ATP that could be relevant during systemic dissemination of bacteria in the host.</p></disp-quote><p>We want to thank the reviewer for recognizing this important aspect of our experimental approach.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>- As pointed out in the limitations of the study whether ATP-loaded OMVs provide a mechanistic proof of the pathogenetic role of bacteria-derived ATP independently of live microorganisms in sepsis is interesting but not definitively convincing. It could be useful to see whether degranulation of neutrophils is differentially induced by apyrase-expressing vs control <italic>E. coli</italic> transformants.</p></disp-quote><p>We thank the reviewer for raising several important points. In our study, we assessed local and systemic effects of released bacterial ATP. The consequences of local bacterial ATP release were assessed using an apyrase-expressing <italic>E. coli</italic> transformant. Locally, bacterial ATP resulted in a decrease in neutrophil numbers and we hypothesize that directly released bacterial ATP either leads to neutrophil death (e.g. via P2X7 receptor (Proietti et al., 2019)) or interferes with the recruitment of neutrophils (e.g. via P2Y receptors (Junger, 2011)).</p><p>The systemic consequences were assessed using ATP-loaded and empty OMV. We have shown that degranulation is induced by OMV-derived bacterial ATP. ATP-containing OMV are engulfed by neutrophils, reach its endolysosomal compartment and might activate purinergic receptors, which then lead to aberrant degranulation. This concept, that needs to be explored in future studies, is fundamentally different from classical purinergic signaling via directly released bacterial ATP into the extracellular space.</p><p>It is possible that neutrophil degranulation is also modulated by directly released bacterial ATP. We agree that this should be assessed in future studies. Also, the role of OMV-derived bacterial ATP should be assessed locally as well as the importance of directly released vs. OMV-mediated bacterial ATP dissected locally. Based on our measurements (Figure 4-figure supplement 1A and Figure 5C), we estimate that the effect of OMV-derived bacterial ATP might be much smaller than the effects of directly released bacterial ATP. Thus, direct ATP release might predominate locally. However, we fully agree that this has to be investigated in a future study to reconcile the different aspects of bacterial ATP signaling. A paragraph will be added to the manuscript, in which we discuss this particular issue.</p><disp-quote content-type="editor-comment"><p>- Also, the increase of neutrophils in bacterial ATP-depleted abdominal sepsis, which has better outcomes than &quot;ATP-proficient&quot; sepsis, seems difficult to correlate to the hypothesized tissue damage induced by ATP delivered via non-infectious OMVs.</p></disp-quote><p>We fully acknowledge the mentioned discrepancy. What we propose is that bacterial ATP exhibits different functions that are dependent on the release mechanism (see above). Locally, in the peritoneal cavity, neutrophil numbers are decreased by directly released bacterial ATP. Remotely, ATP is delivered via OMV and impacts on neutrophil function. We agree that, in particular, in the peritoneal cavity, both effects may play a role. However, the impact of directly released bacterial ATP seems to be dominant (see above).</p><p>We propose that neutrophils are decreased locally because of directly released bacterial ATP, which prevents efficient infection control and, therefore, impairs sepsis survival. In addition, these fewer neutrophils might even be dysregulated by the engulfment of bacterial ATP delivered via OMV, which leads to an upregulated and possibly aberrant degranulation process worsening local and remote tissue damage. We agree that in addition to neutrophil numbers, the function of local neutrophils should be assessed with and without the influence of OMV-delivered bacterial ATP. This could be done by RNA sequencing of primary neutrophils from the peritoneal cavity or neutrophil cell lines as well as degranulation assays.</p><disp-quote content-type="editor-comment"><p>- Are the neutrophils counts affected by ATP delivered via OMVs?</p></disp-quote><p>This is difficult to show in the peritoneal cavity where we have both, directly released bacterial ATP and OMV-derived bacterial ATP. We assessed such putative difference, however, for the systemic organs and the blood, where we did not find any differences in neutrophil numbers.</p><fig id="sa3fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-sa3-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>- A comparison of cytokine profiles in the abdominal fluids of E. coli and OMV treated animals could be helpful in defining the different responses induced by OMV-delivered vs bacterial-released ATP. The analyses performed on OMV treated versus <italic>E. coli</italic> infected mice are not closely related and difficult to combine when trying to draw a hypothesis for bacterial ATP in sepsis.</p></disp-quote><p>We fully agree that there are several open questions that remain to be elucidated, in particular, to differentiate the local role of directly released versus OMV-delivered bacterial ATP. In this study, we laid the foundation for future in vivo research to examine the specific role of bacterial ATP in sepsis. Such future research avenues might be to investigate the local effects of OMV-delivered bacterial ATP, and how neutrophil migration, apoptosis and degranulation are altered. We agree that exploration of the local secretory immune response and cytokine profiles are relevant to understand the different mechanisms of how bacterial ATP alters sepsis. However, such experiments should be ideally performed in systems where the source and the delivery of ATP can be modulated locally.</p><disp-quote content-type="editor-comment"><p>- Also it was not clear why lung neutrophils were used for the RNAseq data generation and analysis.</p></disp-quote><p>Thank you for this remark. We have chosen primary lung neutrophils for four reasons:</p><p>(1) Isolation of primary lung neutrophils allowed us to assess an in vivo response that would not have been possible with cell lines.</p><p>(2) The lung and the respiratory system are among the clinically most important organs affected during sepsis resulting in a significant cause of mortality.</p><p>(3) We show in Figure 6C that specifically in the lung, OMV are engulfed by neutrophils, which shows the relevance of the lung also in our study context.</p><p>(4) And finally, lung neutrophils were chosen to examine specifically distant and not local effects.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>- In their manuscript &quot;Released Bacterial ATP Shapes Local and Systemic Inflammation during Abdominal Sepsis&quot;, Daniel Spari et al. explored the dual role of ATP in exacerbating sepsis, revealing that ATP from both host and bacteria significantly impacts immune responses and disease progression.</p><p>Strengths:</p><p>- The study meticulously examines the complex relationship between ATP release and bacterial growth, membrane integrity, and how bacterial ATP potentially dampens inflammatory responses, thereby impairing survival in sepsis models. Additionally, this compelling paper implies a concept that bacterial OMVs act as vehicles for the systemic distribution of ATP, influencing neutrophil activity and exacerbating sepsis severity.</p></disp-quote><p>We thank the reviewer for mentioning these key points and supporting the relevance of our study.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>(1) The researchers extracted and cultivated abdominal fluid on LB agar plates, then randomly picked 25 colonies for analysis. However, they did not conduct 16S rRNA gene amplicon sequencing on the fluid itself. It is worth noting that the bacterial species present may vary depending on the individual patients. It would be beneficial if the authors could specify whether they've verified the existence of unculturable species capable of secreting high levels of Extracellular ATP.</p></disp-quote><p>Most septic complications are caused by a limited spectrum of bacteria, belonging mainly either to the Firmicutes or the Proteobacteria phyla, including <italic>E. coli</italic>, <italic>K. pneumoniae</italic>, <italic>S. aureus</italic> or <italic>E. faecalis</italic> (Diekema et al., 2019; Mureșan et al., 2018). We validated this well documented existing evidence by randomly assessing 25 colonies. For the planned experiments, it was crucial to work with culturable bacteria; otherwise, ATP measurements, the modulation of ATP generation or loading of OMV would not have been possible. Using such culturable bacteria allowed us to describe mechanisms of ATP release.</p><p>We fully agree that hard-to-culture or unculturable bacteria might contribute significantly to septic complications. This, however, would need to be explored in future studies using extensive culturing methods (Cheng et al., 2022).</p><disp-quote content-type="editor-comment"><p>(2) Do mice lacking commensal bacteria show a lack of extracellular ATP following cecal ligation puncture?</p></disp-quote><p>ATP is typically secreted by many cells of the host in active and passive manners in the case of any injury, including cecal ligation and puncture (Burnstock, 2016; Dosch et al., 2018; Eltzschig et al., 2012; Idzko et al., 2014). We hypothesize that bacterial ATP is a potential priming agent at early stages of sepsis, and indeed, at such early time points, a comparison of peritoneal ATP levels between germfree and colonized mice could support our hypothesis. Future studies addressing this question must, however, correct for the different immune responses between germ-free and colonized mice. This is of utmost importance, especially for the cecal ligation and puncture model, since the cecum of germ-free mice is extremely large, making such experiments hard to control.</p><disp-quote content-type="editor-comment"><p>(3) The authors isolated various bacteria from abdominal fluid, encompassing both Gram-negative and Gram-positive types. Nevertheless, their emphasis appeared to be primarily on the Gram-negative <italic>E. coli</italic>. It would be beneficial to ascertain whether the mechanisms of Extracellular ATP release differ between Gram-positive and Gram-negative bacteria. This is particularly relevant given that the Gram-positive bacterium <italic>E. faecalis</italic>, also isolated from the abdominal fluid, is recognized for its propensity to release substantial amounts of Extracellular ATP.</p></disp-quote><p>We fully agree with this comment. In this paper, we used <italic>E. coli</italic> as our model organism to determine the principles of sepsis-associated bacterial ATP release and therefore focused on gram-negative bacteria. In addition to the direct, growth-dependent release, we found a relevant impact of OMV-delivered bacterial ATP. For this latter purpose, a gram-negative strain, in which OMV generation has been well described (Schwechheimer &amp; Kuehn, 2015), was chosen. Recently, gram-positive bacteria have been shown to secrete ATP and OMV as well (Briaud &amp; Carroll, 2020; Hironaka et al., 2013; Iwase et al., 2010). Given the fundamental differences in the structure of the cell wall of gram-positive bacteria and the mechanisms of OMV generation and release, future studies are required to assess the relevance of directly released and OMV-delivered ATP in gram-positive bacteria.</p><disp-quote content-type="editor-comment"><p>(4) The authors observed changes in the levels of LPM, SPM, and neutrophils in vivo. However, it remains uncertain whether the proliferation or migration of these cells is modulated or inhibited by ATP receptors like P2Y receptors. This aspect requires further investigation to establish a convincing connection.</p></disp-quote><p>We fully agree with this comment. The decrease in LPM and the consequential predomination of SPM have been well described after inflammatory stimuli in the context of the macrophage disappearance reaction (Ghosn et al., 2010). Also, it has been shown that purinergic signaling modulates infiltration of neutrophils and can lead to cell death as a consequence of P2Y and P2X receptor activation (Junger, 2011; Proietti et al., 2019). In our study, we propose that intracellular purinergic receptors contribute to neutrophil function during sepsis. After introducing the general principles and fundaments of bacterial ATP with our studies, we fully agree that additional experiments need to address downstream purinergic receptor activation. That, however, would go beyond the scope of our study.</p><disp-quote content-type="editor-comment"><p>(5) Additionally, is it possible that the observed in vivo changes could be triggered by bacterial components other than Extracellular ATP? In this research field, a comprehensive collection of inhibitors is available, so it is desirable to utilize them to demonstrate clearer results.</p></disp-quote><p>This question is of utmost importance and defined the choice of our model and experimental approach. When we started the project, we used two different <italic>E. coli</italic> mutants that release low (ompC) and high (eaeH) amounts of ATP. However, the limitation of this approach is that these are different bacteria, which may also differ in the components they secrete or the surface proteins they express. We, therefore, decided against that approach. With the approach we finally used (same bacterium, just with and without ATP), we aimed to minimize the influence of non-ATP bacterial components.</p><disp-quote content-type="editor-comment"><p>(6) Have the authors considered the role of host-derived Extracellular ATP in the context of inflammation?</p></disp-quote><p>Yes, the role of host-derived extracellular ATP in inflammation and sepsis is well-established with contradictory results (Csóka et al., 2015; Ledderose et al., 2016). This conflicting data was the rationale to test the relevance of bacterial ATP. We suggest that bacterial ATP is essential in the early phase of sepsis when bacteria invade the sterile compartment and before efficient host response, including the eukaryotic release of ATP, is established.</p><disp-quote content-type="editor-comment"><p>(7) The authors mention that Extracellular ATP is rapidly hydrolyzed by ectonucleotases in vivo. Are the changes of immune cells within the peritoneal cavity caused by Extracellular ATP released from bacterial death or by OMVs?</p></disp-quote><p>This is a relevant question that was also asked by reviewer #1, and we answered it in detail above (weaknesses comment #1 and #2). From our ATP measurements (Figure 4-figure supplement 1A and Figure 5C), we conclude that locally, the role of directly released bacterial ATP (extracellular) predominates over OMV-derived bacterial ATP. Furthermore, the mechanisms between directly released and OMV-derived bacterial ATP (within OMV, engulfed and transported to the endolysosomal compartment) are different, and especially extracellular ATP has been described to lead to apoptosis via P2X7 signaling.</p><disp-quote content-type="editor-comment"><p>(8) In the manuscript, the sample size (n) for the data consistently remains at 2. I would suggest expanding the sample size to enhance the robustness and rigor of the results.</p></disp-quote><p>Two biological replicates (independent cultures) were only used for the bacteria cultures in Figure 1, Figure 2, and Figure 3, which achieved similar results and the standard deviation remained very small, indicating its robustness. In the in vitro experiments in Figure 5 we used a sample size of 6 (three biological replicates measured in technical duplicates), since we saw bigger deviations in our measurements. For the in vivo experiments, we always used 5 or more animals in at least two independent experiments.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>(9). Line 37: 11 million sepsis-related deaths were reported &quot;in&quot; 2017.</p><p>The passage has been corrected as suggested.</p><p>(10) By the way, the similar colors used in Figure 1C and G are too chaotic, making it difficult to distinguish.</p></disp-quote><p>We agree, the colors have been adapted.</p><fig id="sa3fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96678-sa3-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>(11). All &quot;in vivo&quot; and &quot;in vitro&quot; should be italicized.</p></disp-quote><p>We italicized all of them.</p><disp-quote content-type="editor-comment"><p>(12). The title of Figure 4 is confusing: &quot;Impairs sepsis outcome in vivo?&quot; Could you make it more specific?</p></disp-quote><p>We agree, the title has been rephrased:</p><p>“Bacterial ATP reduces neutrophil counts and reduces survival in a mouse model of abdominal sepsis.”</p><disp-quote content-type="editor-comment"><p>(13) Line 314-316: The sentence &quot;Potentially, despite the lack of a transporter, ATP may similarly to eukaryotic cells leak (Yegutkin et al., 2006) across the inner membrane into the periplasmic space that lacks the enzymes for ATP generation.&quot; sounds odd.</p></disp-quote><p>This passage was reformulated in the manuscript.</p><p>“Despite the lack of a transporter, ATP may leak across the inner membrane into the periplasmic space. Such leakage may be similar to baseline leakage in eukaryotic cells (Yegutkin et al., 2006).”</p><disp-quote content-type="editor-comment"><p>(14) The numerical notation in the paper is odd: sometimes it uses a prime symbol as a superscript (such as line 504), and sometimes it does not (such as line 421). Should it be standardized to &quot;3,200&quot; and &quot;150,000&quot;?</p></disp-quote><p>Thank you for this remark. The numbers have been standardized throughout the manuscript.</p><disp-quote content-type="editor-comment"><p>(15) Line &quot;0.4 mm EP cuvettes&quot; should be &quot;0.4 cm EP cuvettes&quot;</p></disp-quote><p>The specified passage has been corrected as suggested.</p><p>References</p><p>Briaud, P., &amp; Carroll, R. K. (2020). Extracellular Vesicle Biogenesis and Functions in Gram-Positive Bacteria. Infection and Immunity, 88(12), 10.1128/iai.00433-20. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/iai.00433-20">https://doi.org/10.1128/iai.00433-20</ext-link></p><p>Burnstock, G. (2016). P2X ion channel receptors and inflammation. Purinergic Signalling, 12(1), 59–67. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11302-015-9493-0">https://doi.org/10.1007/s11302-015-9493-0</ext-link></p><p>Cheng, A. G., Ho, P.-Y., Aranda-Díaz, A., Jain, S., Yu, F. B., Meng, X., Wang, M., Iakiviak, M., Nagashima, K., Zhao, A., Murugkar, P., Patil, A., Atabakhsh, K., Weakley, A., Yan, J., Brumbaugh, A. R., Higginbottom, S., Dimas, A., Shiver, A. L., … Fischbach, M. A. (2022). Design, construction, and in vivo augmentation of a complex gut microbiome. Cell, 185(19), 3617-3636.e19. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2022.08.003">https://doi.org/10.1016/j.cell.2022.08.003</ext-link></p><p>Csóka, B., Németh, Z. H., Törő, G., Idzko, M., Zech, A., Koscsó, B., Spolarics, Z., Antonioli, L., Cseri, K., Erdélyi, K., Pacher, P., &amp; Haskó, G. (2015). Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. The FASEB Journal, 29(9), 3626–3637. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1096/fj.15-272450">https://doi.org/10.1096/fj.15-272450</ext-link></p><p>Diekema, D. J., Hsueh, P.-R., Mendes, R. E., Pfaller, M. A., Rolston, K. V., Sader, H. S., &amp; Jones, R. N. (2019). The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program. Antimicrobial Agents and Chemotherapy, 63(7), e00355-19. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.00355-19">https://doi.org/10.1128/AAC.00355-19</ext-link></p><p>Dosch, M., Gerber, J., Jebbawi, F., &amp; Beldi, G. (2018). Mechanisms of ATP Release by Inflammatory Cells. International Journal of Molecular Sciences, 19(4), 1222. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms19041222">https://doi.org/10.3390/ijms19041222</ext-link></p><p>Eltzschig, H. K., Sitkovsky, M. V., &amp; Robson, S. C. (2012). Purinergic Signaling during Inflammation. New England Journal of Medicine, 367(24), 2322–2333. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMra1205750">https://doi.org/10.1056/NEJMra1205750</ext-link></p><p>Ghosn, E. E. B., Cassado, A. A., Govoni, G. R., Fukuhara, T., Yang, Y., Monack, D. M., Bortoluci, K. R., Almeida, S. R., Herzenberg, L. A., &amp; Herzenberg, L. A. (2010). Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proceedings of the National Academy of Sciences, 107(6), 2568–2573. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0915000107">https://doi.org/10.1073/pnas.0915000107</ext-link></p><p>Hironaka, I., Iwase, T., Sugimoto, S., Okuda, K., Tajima, A., Yanaga, K., &amp; Mizunoe, Y. (2013). Glucose Triggers ATP Secretion from Bacteria in a Growth-Phase-Dependent Manner. Applied and Environmental Microbiology, 79(7), 2328–2335. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AEM.03871-12">https://doi.org/10.1128/AEM.03871-12</ext-link></p><p>Idzko, M., Ferrari, D., &amp; Eltzschig, H. K. (2014). Nucleotide signalling during inflammation. Nature, 509(7500), 310–317. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature13085">https://doi.org/10.1038/nature13085</ext-link></p><p>Iwase, T., Shinji, H., Tajima, A., Sato, F., Tamura, T., Iwamoto, T., Yoneda, M., &amp; Mizunoe, Y. (2010). Isolation and Identification of ATP-Secreting Bacteria from Mice and Humans. Journal of Clinical Microbiology, 48(5), 1949–1951. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JCM.01941-09">https://doi.org/10.1128/JCM.01941-09</ext-link></p><p>Junger, W. G. (2011). Immune cell regulation by autocrine purinergic signalling. Nature Reviews Immunology, 11(3), 201–212. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nri2938">https://doi.org/10.1038/nri2938</ext-link></p><p>Ledderose, C., Bao, Y., Kondo, Y., Fakhari, M., Slubowski, C., Zhang, J., &amp; Junger, W. G. (2016). Purinergic Signaling and the Immune Response in Sepsis: A Review. Clinical Therapeutics, 38(5), 1054–1065. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clinthera.2016.04.002">https://doi.org/10.1016/j.clinthera.2016.04.002</ext-link></p><p>Mureșan, M. G., Balmoș, I. A., Badea, I., &amp; Santini, A. (2018). Abdominal Sepsis: An Update. The Journal of Critical Care Medicine, 4(4), 120–125. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2478/jccm-2018-0023">https://doi.org/10.2478/jccm-2018-0023</ext-link></p><p>Proietti, M., Perruzza, L., Scribano, D., Pellegrini, G., D’Antuono, R., Strati, F., Raffaelli, M., Gonzalez, S. F., Thelen, M., Hardt, W.-D., Slack, E., Nicoletti, M., &amp; Grassi, F. (2019). ATP released by intestinal bacteria limits the generation of protective IgA against enteropathogens. Nature Communications, 10(1), Article 1. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-018-08156-z">https://doi.org/10.1038/s41467-018-08156-z</ext-link></p><p>Schwechheimer, C., &amp; Kuehn, M. J. (2015). Outer-membrane vesicles from Gram-negative bacteria: Biogenesis and functions. Nature Reviews Microbiology, 13(10), 605–619. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrmicro3525">https://doi.org/10.1038/nrmicro3525</ext-link></p></body></sub-article></article>